Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Emergent BioSolutions Inc. (EBS)
USD7.73
+0.23 (+3.00%)
US NYSE Healthcare Biotechnology
Address
400 Professional Drive 20879
Gaithersburg, MD, US
Gaithersburg, MD, US
CEO
Joseph C. Papa Jr.
Website
emergentbiosolutions.com
IPO
2006-11-15
CIK 1367644 ISIN US29089Q1058
Also trades on
London Stock Exchange · 0IGA.L (USD)
New York Stock Exchange · EBS (USD)
Description
Emergent BioSolutions Inc. is a life sciences company dedicated to providing vital preparedness and response solutions for a wide range of public health threats (PHTs) across the United States. These threats encompass accidental, deliberate, and naturally occurring events, including chemical, biological, radiological, nuclear, and explosives (CBRNE) incidents, emerging infectious diseases, travel-related health risks, and acute emergency care situations. The company's current product portfolio features essential vaccines and treatments such as BioThrax for anthrax and ACAM2000 for smallpox. It also offers Botulism Antitoxin Heptavalent, vaccinia immune globulin intravenous to manage smallpox vaccine complications, and inhalational anthrax therapies like raxibacumab and Anthrasil. Other key offerings include reactive skin decontamination lotion kits, the Trobigard combination drug-device auto-injector, NARCAN nasal spray for emergency opioid overdose reversal, Vivotif, an oral typhoid fever vaccine, and Vaxchora, a single-dose oral cholera vaccine. Emergent is also actively engaged in developing a robust pipeline of future solutions. This includes AP003 (a multidose naloxone nasal spray), AP007 (a sustained-release nalmefene injection for opioid use disorder), AV7909 (an anthrax vaccine), CGRD-001 (a pralidoxime chloride/atropine auto-injector), CHIKV VLP (a chikungunya virus vaccine), COVID-HIG (for SARS-CoV2 treatment), EGRD-001 (a diazepam auto-injector), SIAN (a cyanide poisoning antidote), and UniFlu (a universal influenza vaccine). Furthermore, the company extends its expertise through comprehensive contract development and manufacturing services (CDMO). These services cover drug substance and product manufacturing, packaging, along with technology transfer and advanced process and analytical development. Emergent BioSolutions Inc., founded in 1998, is headquartered in Gaithersburg, Maryland.
Market Cap & Enterprise Value
Merger & Acquisition History
| Target company | Date | Filing |
|---|---|---|
| TRUBION PHARMACEUTICALS | 2010-09-13 | View |
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD7.73
+0.23 (+3.00%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
806.0K
Beta
2.34
Float Shares
49.78M
Free Float %
96.4%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -5.03% | -6.28% | +6.78% | -21.66% | -21.37% | -31.23% | +45.55% | -7.41% | -85.49% | -78.14% | -27.35% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Analyst Consensus (15 ratings, all time)
Buy
Price Targets & DCF
Current price
7.73
Low
12.00
+55.3%
Consensus
12.00
+55.3%
Median
12.00
+55.3%
High
12.00
+55.3%
DCF (Unlevered)
2.64
-65.9%
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
Ratings Trend (MoM)
100% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 2 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Price Target Summary
| Period | # Analysts | Avg Target |
|---|---|---|
| Last Month | — | — |
| Last Quarter | 1 |
12.00
+55.3%
|
| Last Year | 1 |
12.00
+55.3%
|
| All Time | 3 |
38.33
+396.2%
|
Quality scores
Altman Z-Score
1.34
Distress
Piotroski F-Score
4 / 9
Average
MOAT Score
3 / 10
No MOAT
Composite Rating
C-
Overall Score
1 / 5
Low
DCF Score
1 / 5
Low
ROE Score
1 / 5
Low
ROA Score
1 / 5
Low
D/E Score
1 / 5
Low
P/E Score
1 / 5
Low
P/Book Score
4 / 5
High
Operational MOAT
✗ Below peers
-
Revenue growth Biotechnology: +1.6%-28.8% Q1'26: -29.7% (vs Q1'25)
-
EPS growth Biotechnology: +29.7%+125.8% ★ Q1'26: -93.8% (vs Q1'25)
-
FCF margin FCF growth · Biotechnology: +16.2%+11.2% ★ Q1'26: -23.2% (vs Q1'25)
-
EBIT margin Biotechnology: +0.0%+14.8% ★ Q1'26: +6.7% (vs Q1'25)
-
ROIC Biotechnology: -16.1%+7.9% ★ Q1'26: +2.7% (vs Q1'25)
-
Share dilution Biotechnology: -3.4%+7.0% Q1'26: -1.4% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Biotechnology: 0.16×2.74× Q1'26: 4.14× (vs Q1'25)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Dec 2015 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 1 Rev. Ana. 1 EPS Ana. |
Dec 2027 1 Rev. Ana. 1 EPS Ana. |
Dec 2028 1 Rev. Ana. 1 EPS Ana. |
Dec 2029 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
489.33M
est: 524.64M (-6.7%)
|
488.80M
est: 475.78M (+2.7%)
|
560.90M
est: 556.03M (+0.9%)
|
782.40M
est: 782.75M (0.0%)
|
1.11B
est: 1.10B (+0.2%)
|
1.58B
est: 1.55B (+2.0%)
|
1.77B
est: 1.74B (+2.0%)
|
1.12B
est: 1.09B (+2.8%)
|
1.05B
est: 1.10B (-4.8%)
|
1.04B
est: 1.10B (-5.0%)
|
742.90M
est: 809.40M (-8.2%)
|
733.05M
730.09M – 736.01M
-9.4% YoY
|
892.00M
888.40M – 895.60M
+21.7% YoY
|
878.60M
875.06M – 882.14M
-1.5% YoY
|
963.20M
959.32M – 967.08M
+9.6% YoY
|
| EBITDA |
186.68M
est: 101.92M (+83.2%)
|
132.90M
est: 136.88M (-2.9%)
|
174.70M
est: 158.18M (+10.4%)
|
155.10M
est: 135.60M (+14.4%)
|
258.90M
est: 206.73M (+25.2%)
|
609.20M
est: 492.55M (+23.7%)
|
504.20M
est: 438.36M (+15.0%)
|
15.70M
est: 211.95M (-92.6%)
|
-47.00M
est: 129.04M (-136.4%)
|
53.40M
est: 128.60M (-58.5%)
|
208.50M
est: 94.76M (+120.0%)
|
85.82M
85.47M – 86.17M
-9.4% YoY
|
104.43M
104.01M – 104.85M
+21.7% YoY
|
102.86M
102.45M – 103.27M
-1.5% YoY
|
112.76M
112.31M – 113.22M
+9.6% YoY
|
| EBIT |
151.34M
est: 71.96M (+110.3%)
|
94.70M
est: 75.42M (+25.6%)
|
132.10M
est: 113.89M (+16.0%)
|
92.90M
est: 66.01M (+40.7%)
|
150.90M
est: 37.86M (+298.6%)
|
499.20M
est: 381.82M (+30.7%)
|
386.00M
est: 278.66M (+38.5%)
|
-109.30M
est: -69.63M (-57.0%)
|
-168.10M
est: 12.77M (-1,416.0%)
|
-52.20M
est: 12.73M (-510.1%)
|
110.20M
est: 9.38M (+1,074.8%)
|
8.50M
8.46M – 8.53M
-9.4% YoY
|
10.34M
10.30M – 10.38M
+21.7% YoY
|
10.18M
10.14M – 10.22M
-1.5% YoY
|
11.16M
11.12M – 11.21M
+9.6% YoY
|
| Net Income |
62.87M
est: 46.41M (+35.5%)
|
51.80M
est: 41.71M (+24.2%)
|
82.60M
est: 75.00M (+10.1%)
|
62.70M
est: 48.96M (+28.1%)
|
54.50M
est: -13.34M (+508.7%)
|
305.80M
est: 267.72M (+14.2%)
|
219.50M
est: 166.73M (+31.6%)
|
-211.60M
est: -608.00M (+65.2%)
|
-760.50M
est: -638.21M (-19.2%)
|
-190.60M
est: -47.44M (-301.8%)
|
52.60M
est: 116.24M (-54.7%)
|
18.43M
18.33M – 18.52M
-84.1% YoY
|
51.60M
51.33M – 51.87M
+180.0% YoY
|
24.38M
24.25M – 24.51M
-52.7% YoY
|
51.03M
50.76M – 51.30M
+109.3% YoY
|
| SGA |
121.15M
est: 127.63M (-5.1%)
|
143.10M
est: 246.71M (-42.0%)
|
142.90M
est: 145.59M (-1.8%)
|
202.50M
est: 220.83M (-8.3%)
|
273.50M
est: 415.85M (-34.2%)
|
304.10M
est: 281.75M (+7.9%)
|
348.70M
est: 450.49M (-22.6%)
|
339.50M
est: 664.91M (-48.9%)
|
356.70M
est: 303.71M (+17.4%)
|
298.70M
est: 302.68M (-1.3%)
|
186.60M
est: 223.03M (-16.3%)
|
201.99M
201.18M – 202.81M
-9.4% YoY
|
245.79M
244.80M – 246.78M
+21.7% YoY
|
242.10M
241.12M – 243.07M
-1.5% YoY
|
265.41M
264.34M – 266.48M
+9.6% YoY
|
| EPS |
1.63
est: 1.53 (+6.8%)
|
1.29
est: 1.04 (+24.5%)
|
1.98
est: 1.83 (+8.2%)
|
1.25
est: 2.24 (-44.2%)
|
1.06
est: 2.96 (-64.2%)
|
5.79
est: 7.35 (-21.2%)
|
4.10
est: 5.89 (-30.3%)
|
-4.22
est: -1.90 (-121.9%)
|
-14.85
est: -11.26 (-31.9%)
|
-3.60
est: -0.84 (-330.3%)
|
0.98
est: 2.05 (-52.2%)
|
0.33
0.32 – 0.33
-84.1% YoY
|
0.91
0.91 – 0.91
+180.0% YoY
|
0.43
0.43 – 0.43
-52.7% YoY
|
0.90
0.90 – 0.90
+109.3% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-11 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-08 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-07 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-06 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-05 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-04 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-01 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-30 | B | 3/5 | 1/5 | 3/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-29 | B | 3/5 | 1/5 | 3/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-28 | B | 3/5 | 1/5 | 3/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-27 | B | 3/5 | 1/5 | 3/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-24 | B | 3/5 | 1/5 | 3/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-23 | B | 3/5 | 1/5 | 3/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-22 | B | 3/5 | 1/5 | 3/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-21 | B | 3/5 | 1/5 | 3/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-20 | B | 3/5 | 1/5 | 3/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-17 | B | 3/5 | 1/5 | 3/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-16 | B | 3/5 | 1/5 | 3/5 | 5/5 | 1/5 | 3/5 | 4/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
21.56M
OE per share TTM
0.50
Owner's Yield
4.64%
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
45.0%
Ownership Overview
Ownership breakdown
At a glance
Institutional holders
39
Total invested
8.62M
Insider transactions (90d)
7
Beneficial owners (>5%)
27
Beneficial owners (>5%)
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Fuad El-Hibri | 22.45M | 81.40% | 22.45M | — | 151.0K | — | IN | United States | 2007-02-14 | ↗ |
| 2 | Intervac, L.L.C. | 8.31M | 30.10% | — | — | — | — | OO | Maryland, United States | 2007-02-14 | ↗ |
| 3 | (1) BlackRock, Inc. | 8.08M | 15.00% | 7.94M | — | 8.08M | — | HC | Delaware | 2022-01-27 | ↗ |
| 4 | The Vanguard Group - 23-1945930 | 5.35M | 10.60% | — | 48.8K | 5.26M | 92.7K | IA | Pennsylvania | 2022-03-09 | ↗ |
| 5 | BioPharm, L.L.C. | 4.07M | 14.80% | — | — | — | — | OO | Maryland, United States | 2007-02-14 | ↗ |
| 6 | Oak Hill Advisors, L.P. | 3.61M | 6.39% | 3.61M | — | 3.61M | — | IA, PN | Delaware | 2024-11-13 | ↗ |
| 7 | STATE STREET CORPORATION | 3.03M | 5.64% | — | 2.93M | — | 3.03M | HC | — | 2022-02-10 | ↗ |
| 8 | Charles Schwab Investment Management, Inc. | 2.87M | 5.54% | 2.87M | — | 2.87M | — | IA | — | 2024-02-09 | ↗ |
| 9 | Israel A. Englander | 2.71M | 5.20% | — | 2.71M | — | 2.71M | IN | Delaware | 2023-09-07 | ↗ |
| 10 | Millennium Group Management LLC | 2.71M | 5.20% | — | 2.71M | — | 2.71M | OO | Delaware | 2023-09-07 | ↗ |
| 11 | Millennium Management LLC | 2.71M | 5.20% | — | 2.71M | — | 2.71M | OO | Delaware | 2023-09-07 | ↗ |
| 12 | Robert Calvin Myers | 2.39M | 8.70% | 459.2K | — | 459.2K | — | IN | United States | 2007-02-14 | ↗ |
| 13 | (. | 2.25M | 5.43% | 2.12M | — | 2.25M | — | IA | Delaware | 2018-02-09 | ↗ |
| 14 | Scopia Management Inc. | 1.96M | 5.45% | — | 1.96M | — | 1.96M | IA | United States | 2012-02-10 | ↗ |
| 15 | Michigan Biologic Products, Inc. | 1.93M | 7.00% | — | — | — | — | CO | Michigan, United States | 2007-02-14 | ↗ |
| 16 | Broadfin Capital, LLC | 1.91M | 5.10% | — | 1.91M | — | 1.91M | OO | Delaware | 2014-05-19 | ↗ |
| 17 | Broadfin Healthcare Master Fund, Ltd. | 1.91M | 5.10% | — | 1.91M | — | 1.91M | CO | Delaware | 2014-05-19 | ↗ |
| 18 | Kevin Kotler | 1.91M | 5.10% | — | 1.91M | — | 1.91M | HC, IN | Delaware | 2014-05-19 | ↗ |
| 19 | 52-2343049 | 1.90M | 5.29% | 1.90M | — | 1.90M | — | IA | New York | 2012-01-11 | ↗ |
| 20 | Biovac, L.L.C. | 1.60M | 5.80% | — | — | — | — | OO | Maryland, United States | 2007-02-14 | ↗ |
| 21 | Mauro Gibellini | 1.45M | 5.20% | 71.9K | — | 71.9K | — | IN | Italy | 2007-02-14 | ↗ |
| 22 | Biologika, L.L.C. | 1.38M | 5.00% | — | — | — | — | OO | Maryland, United States | 2007-02-14 | ↗ |
| 23 | Yasmine Gibellini | 1.38M | 5.00% | — | — | — | — | IN | Germany | 2007-02-14 | ↗ |
| 24 | Intervac Management, L.L.C. | 719.3K | 2.60% | — | — | — | — | OO | Maryland, United States | 2007-02-14 | ↗ |
| 25 | ARPI, L.L.C. | 658.3K | 2.40% | — | — | — | — | OO | Maryland, United States | 2007-02-14 | ↗ |
| 26 | Neuberger Berman Group LLC | 646.4K | 1.20% | — | 542.5K | — | 646.4K | HC | — | 2022-02-11 | ↗ |
| 27 | Neuberger Berman Investment Advisers LLC | 646.4K | 1.20% | — | 542.5K | — | 646.4K | IA | — | 2022-02-11 | ↗ |
Institutional Activity (13F)
Institutional ownership trend
From
To
13F snapshot — 2026 Q1
Investors holding
39
-152 vs prev Q
New positions
9
Closed positions
153
Increased
20
Reduced
9
Put/Call ratio
0.00
Calls held
400.00
Puts held
—
Top institutional holders
| # | Investor | Shares / Δ | Mkt value / Δ | Own% / Δ | Weight% / Δ | Avg px / Perf. | Hold / Status |
|---|---|---|---|---|---|---|---|
| 1 | BLACKROCK, INC. | 4.25M -8.7K (-0.2%) | 52.58M +15.0M (+39.8%) | 8.00% +0.131 pp | 0.00% +0.000 pp | USD7.21 +71.4% | 6 qtrs — |
| 2 | OAK HILL ADVISORS LP | 3.61M +— (+0.0%) | 44.66M +28.1M (+169.6%) | 6.79% +0.125 pp | 7.29% +3.835 pp | USD6.99 +76.8% | 6 qtrs — |
| 3 | VANGUARD GROUP INC | 3.55M +13.3K (+0.4%) | 43.93M +12.7M (+40.7%) | 6.68% +0.148 pp | 0.00% +0.000 pp | USD28.59 -56.8% | 76 qtrs — |
| 4 | STATE STREET CORP | 2.70M +250.6K (+10.2%) | 33.33M +11.8M (+54.5%) | 5.07% +0.556 pp | 0.00% +0.000 pp | USD10.21 +21.1% | 51 qtrs — |
| 5 | AMERICAN CENTURY COMPANIES INC | 2.44M +57.1K (+2.4%) | 30.15M +9.1M (+43.5%) | 4.59% +0.190 pp | 0.02% +0.005 pp | USD8.94 +38.3% | 22 qtrs — |
| 6 | DIMENSIONAL FUND ADVISORS LP | 2.25M +112.3K (+5.2%) | 27.84M +9.0M (+47.5%) | 4.23% +0.285 pp | 0.01% +0.002 pp | USD10.18 +21.4% | 51 qtrs — |
| 7 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 1.62M +237.2K (+17.2%) | 20.01M +7.8M (+64.2%) | 3.04% +0.494 pp | 0.00% +0.001 pp | USD8.66 +42.7% | 70 qtrs — |
| 8 | PALISADE CAPITAL MANAGEMENT, LP | 1.27M -160.3K (-11.2%) | 15.64M +3.1M (+24.4%) | 2.38% -0.252 pp | 0.46% +0.122 pp | USD26.71 -53.7% | 25 qtrs — |
| 9 | GEODE CAPITAL MANAGEMENT, LLC | 1.25M -28.7K (-2.2%) | 15.45M +4.2M (+37.0%) | 2.35% -0.010 pp | 0.00% +0.000 pp | USD20.86 -40.7% | 76 qtrs — |
| 10 | MORGAN STANLEY | 1.16M +628.8K (+118.9%) | 14.31M +9.6M (+206.8%) | 2.18% +1.200 pp | 0.00% +0.001 pp | USD12.91 -4.3% | 49 qtrs — |
| 11 | ACADIAN ASSET MANAGEMENT LLC | 1.11M -67.0K (-5.7%) | 13.72M +3.3M (+32.2%) | 2.09% -0.085 pp | 0.02% +0.004 pp | USD6.21 +99.0% | 50 qtrs — |
| 12 | JAIN GLOBAL LLC | 942.7K +434.0K (+85.3%) | 11.65M +7.2M (+159.7%) | 1.77% +0.833 pp | 0.06% +0.035 pp | USD10.45 +18.3% | 5 qtrs — |
| 13 | LSV ASSET MANAGEMENT | 901.0K +36.5K (+4.2%) | 11.14M +3.5M (+46.0%) | 1.69% +0.099 pp | 0.02% +0.007 pp | USD5.49 +125.1% | 5 qtrs — |
| 14 | CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 778.0K -354.3K (-31.3%) | 9.62M -370.9K (-3.7%) | 1.46% -0.627 pp | 0.03% -0.006 pp | USD4.62 +167.5% | 12 qtrs — |
| 15 | PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. | 772.8K +— (+0.0%) | 9.55M +2.7M (+40.1%) | 1.45% +0.027 pp | 0.89% +0.169 pp | USD6.33 +95.3% | 6 qtrs — |
| 16 | MARSHALL WACE, LLP | 743.5K -168.9K (-18.5%) | 9.19M +1.1M (+14.2%) | 1.40% -0.286 pp | 0.01% +0.000 pp | USD7.64 +61.8% | 12 qtrs — |
| 17 | GOLDMAN SACHS GROUP INC | 740.1K +119.1K (+19.2%) | 9.15M +3.7M (+67.0%) | 1.39% +0.246 pp | 0.00% +0.001 pp | USD12.00 +3.0% | 73 qtrs — |
| 18 | D. E. SHAW & CO., INC. | 723.2K +402.1K (+125.2%) | 8.94M +6.1M (+215.6%) | 1.36% +0.767 pp | 0.00% +0.003 pp | USD12.56 -1.6% | 66 qtrs — |
| 19 | NORTHERN TRUST CORP | 580.6K -57.2K (-9.0%) | 7.18M +1.6M (+27.6%) | 1.09% -0.085 pp | 0.00% +0.000 pp | USD13.72 -9.9% | 51 qtrs — |
| 20 | RENAISSANCE TECHNOLOGIES LLC | 577.1K +58.9K (+11.4%) | 7.13M +2.6M (+56.1%) | 1.08% +0.129 pp | 0.01% +0.005 pp | USD7.34 +68.4% | 9 qtrs — |
| 21 | NEW YORK STATE COMMON RETIREMENT FUND | 522.0K +— (+0.0%) | 6.45M +1.8M (+40.1%) | 0.98% +0.018 pp | 0.01% +0.003 pp | USD19.03 -35.0% | 65 qtrs — |
| 22 | AQR CAPITAL MANAGEMENT LLC | 478.0K -108.2K (-18.5%) | 5.91M +737.7K (+14.3%) | 0.90% -0.183 pp | 0.00% 0.000 pp | USD8.82 +40.1% | 2 qtrs — |
| 23 | FEDERATED HERMES, INC. | 434.8K +33.5K (+8.4%) | 5.37M +1.8M (+51.8%) | 0.82% +0.077 pp | 0.01% +0.003 pp | USD8.46 +46.1% | 42 qtrs — |
| 24 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 377.7K +98.8K (+35.4%) | 4.67M +2.2M (+89.7%) | 0.71% +0.195 pp | 0.00% +0.000 pp | USD9.64 +28.2% | 27 qtrs — |
| 25 | O'SHAUGHNESSY ASSET MANAGEMENT, LLC | 373.9K +225.9K (+152.7%) | 4.62M +3.3M (+254.1%) | 0.70% +0.430 pp | 0.03% +0.018 pp | USD10.96 +12.8% | 2 qtrs — |
| 26 | UBS GROUP AG | 347.8K -91.6K (-20.8%) | 4.30M +423.6K (+10.9%) | 0.65% -0.157 pp | 0.00% +0.000 pp | USD9.37 +31.9% | 45 qtrs — |
| 27 | HRT FINANCIAL LP | 311.8K +311.8K (+100.0%) | 3.85M +3.9M (+100.0%) | 0.59% +0.586 pp | 0.01% +0.012 pp | USD12.36 +0.0% | 1 qtrs NEW |
| 28 | VALUES FIRST ADVISORS, INC. | 305.0K -62.9K (-17.1%) | 3.77M +525.3K (+16.2%) | 0.57% -0.105 pp | 1.96% +0.219 pp | USD3.82 +223.6% | 19 qtrs — |
| 29 | TREXQUANT INVESTMENT LP | 301.7K -224.6K (-42.7%) | 3.73M -913.0K (-19.7%) | 0.57% -0.404 pp | 0.03% -0.015 pp | USD8.35 +48.0% | 6 qtrs — |
| 30 | ALLIANZ ASSET MANAGEMENT GMBH | 290.7K +10.9K (+3.9%) | 3.59M +1.1M (+45.6%) | 0.55% +0.030 pp | 0.00% +0.001 pp | USD8.01 +54.3% | 3 qtrs — |
| 31 | RUSSELL INVESTMENTS GROUP, LTD. | 270.0K +106.3K (+64.9%) | 3.34M +1.9M (+131.1%) | 0.51% +0.205 pp | 0.00% +0.002 pp | USD7.90 +56.5% | 37 qtrs — |
| 32 | TWO SIGMA INVESTMENTS, LP | 258.5K -2.8K (-1.1%) | 3.20M +890.1K (+38.6%) | 0.49% +0.004 pp | 0.00% +0.001 pp | USD8.17 +51.3% | 19 qtrs — |
| 33 | BANK OF NEW YORK MELLON CORP | 244.5K +91.2K (+59.5%) | 3.02M +1.7M (+123.5%) | 0.46% +0.177 pp | 0.00% +0.000 pp | USD8.80 +40.5% | 66 qtrs — |
| 34 | GLOBEFLEX CAPITAL L P | 241.3K +— (+0.0%) | 2.98M +854.2K (+40.1%) | 0.45% +0.008 pp | 0.46% +0.129 pp | USD8.82 +40.1% | 2 qtrs — |
| 35 | MILLENNIUM MANAGEMENT LLC | 237.7K +159.9K (+205.4%) | 2.94M +2.3M (+328.0%) | 0.45% +0.303 pp | 0.00% +0.001 pp | USD10.36 +19.3% | 26 qtrs — |
| 36 | CITADEL ADVISORS LLC | 232.0K -107.6K (-31.7%) | 2.87M -128.0K (-4.3%) | 0.44% -0.191 pp | 0.00% +0.000 pp | USD7.41 +66.8% | 52 qtrs — |
| 37 | MORSE ASSET MANAGEMENT, INC | 229.3K +11.4K (+5.2%) | 2.83M +912.1K (+47.5%) | 0.43% +0.029 pp | 0.57% +0.183 pp | USD8.79 +40.6% | 7 qtrs — |
| 38 | CETERA INVESTMENT ADVISERS | 219.5K +3.5K (+1.6%) | 2.71M +807.7K (+42.4%) | 0.41% +0.014 pp | 0.00% +0.001 pp | USD6.13 +101.6% | 8 qtrs — |
| 39 | TRUIST FINANCIAL CORP | 219.5K -49.8K (-18.5%) | 2.71M +337.3K (+14.2%) | 0.41% -0.084 pp | 0.00% +0.000 pp | USD4.80 +157.5% | 10 qtrs — |
| 40 | INVESCO LTD. | 206.0K -174.3K (-45.8%) | 2.55M -807.9K (-24.1%) | 0.39% -0.314 pp | 0.00% 0.000 pp | USD10.65 +16.1% | 57 qtrs — |
| 41 | DEUTSCHE BANK AG\ | 181.7K +1.9K (+1.1%) | 2.25M +660.5K (+41.6%) | 0.34% +0.010 pp | 0.00% +0.000 pp | USD8.50 +45.4% | 50 qtrs — |
| 42 | JANE STREET GROUP, LLC | 181.0K -317.3K (-63.7%) | 2.24M -2.2M (-49.1%) | 0.34% -0.579 pp | 0.00% 0.000 pp | USD8.35 +48.0% | 6 qtrs — |
| 43 | SQUAREPOINT OPS LLC | 178.3K +5.5K (+3.2%) | 2.20M +679.7K (+44.6%) | 0.34% +0.016 pp | 0.00% +0.001 pp | USD8.45 +46.3% | 14 qtrs — |
| 44 | WOLVERINE ASSET MANAGEMENT LLC | 174.9K +— (+0.0%) | 2.16M +619.3K (+40.1%) | 0.33% +0.006 pp | 0.02% +0.006 pp | USD8.86 +39.5% | 5 qtrs — |
| 45 | ANCORA ADVISORS, LLC | 170.5K +170.5K (+100.0%) | 2.11M +2.1M (+100.0%) | 0.32% +0.320 pp | 0.04% +0.043 pp | USD12.36 +0.0% | 1 qtrs NEW |
| 46 | WELLINGTON MANAGEMENT GROUP LLP | 168.6K -15.5K (-8.4%) | 2.08M +460.6K (+28.4%) | 0.32% -0.023 pp | 0.00% +0.000 pp | USD7.12 +73.6% | 7 qtrs — |
| 47 | COPPELL ADVISORY SOLUTIONS LLC | 161.3K +161.3K (+100.0%) | 1.96M +2.0M (+100.0%) | 0.30% +0.303 pp | 0.19% +0.193 pp | USD12.36 +0.0% | 1 qtrs NEW |
| 48 | SUSQUEHANNA PORTFOLIO STRATEGIES, LLC | 156.4K +— (+0.0%) | 1.93M +553.8K (+40.1%) | 0.29% +0.005 pp | 0.03% +0.008 pp | USD6.24 +98.1% | 4 qtrs — |
| 49 | BARCLAYS PLC | 154.9K +115.6K (+294.0%) | 1.91M +1.6M (+483.3%) | 0.29% +0.219 pp | 0.00% +0.000 pp | USD11.21 +10.3% | 51 qtrs — |
| 50 | BANK OF AMERICA CORP /DE/ | 146.9K +57.4K (+64.2%) | 1.82M +1.0M (+130.1%) | 0.28% +0.111 pp | 0.00% +0.000 pp | USD10.15 +21.8% | 52 qtrs — |
| 51 | BRANDYWINE GLOBAL INVESTMENT MANAGEMENT, LLC | 130.3K -5.1K (-3.8%) | 1.61M +416.3K (+34.9%) | 0.24% -0.005 pp | 0.01% +0.003 pp | USD8.82 +40.1% | 2 qtrs — |
| 52 | CREDIT AGRICOLE S A | 125.0K +125.0K (+100.0%) | 1.55M +1.5M (+100.0%) | 0.24% +0.235 pp | 0.00% +0.004 pp | USD12.36 +0.0% | 1 qtrs NEW |
| 53 | FMR LLC | 118.3K -69.9K (-37.1%) | 1.46M -197.4K (-11.9%) | 0.22% -0.125 pp | 0.00% +0.000 pp | USD8.05 +53.5% | 59 qtrs — |
| 54 | PALUMBO WEALTH MANAGEMENT LLC | 117.1K +68.9K (+143.0%) | 1.45M +1.0M (+240.5%) | 0.22% +0.131 pp | 0.36% +0.221 pp | USD10.90 +13.4% | 2 qtrs — |
| 55 | FULLER & THALER ASSET MANAGEMENT, INC. | 110.2K -1.9K (-1.7%) | 1.36M +373.2K (+37.8%) | 0.21% +0.000 pp | 0.00% +0.001 pp | USD2.58 +379.1% | 8 qtrs — |
| 56 | RITHOLTZ WEALTH MANAGEMENT | 108.9K +108.9K (+100.0%) | 1.35M +1.3M (+100.0%) | 0.20% +0.205 pp | 0.02% +0.025 pp | USD12.36 +0.0% | 1 qtrs NEW |
| 57 | SEGALL BRYANT & HAMILL, LLC | 106.0K +25.1K (+31.1%) | 1.31M +596.8K (+83.7%) | 0.20% +0.050 pp | 0.02% +0.008 pp | USD9.66 +28.0% | 2 qtrs — |
| 58 | NUVEEN, LLC | 105.4K -8.8K (-7.7%) | 1.30M +295.8K (+29.4%) | 0.20% -0.013 pp | 0.00% +0.000 pp | USD6.38 +93.7% | 3 qtrs — |
| 59 | SILVER OAK SECURITIES, INCORPORATED | 106.7K +— (+0.0%) | 1.30M +356.4K (+37.9%) | 0.20% +0.004 pp | 0.09% +0.017 pp | USD8.82 +40.1% | 2 qtrs — |
| 60 | CAMPBELL & CO INVESTMENT ADVISER LLC | 100.5K +55.9K (+125.3%) | 1.24M +848.8K (+215.7%) | 0.19% +0.107 pp | 0.06% +0.030 pp | USD10.79 +14.6% | 6 qtrs — |
| 61 | UNIVERSAL- BETEILIGUNGS- UND SERVICEGESELLSCHAFT MBH | 96.7K +— (+0.0%) | 1.20M +342.3K (+40.1%) | 0.18% +0.003 pp | 0.00% +0.001 pp | USD4.86 +154.3% | 4 qtrs — |
| 62 | SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | 95.1K +— (+0.0%) | 1.18M +336.5K (+40.1%) | 0.18% +0.003 pp | 0.04% +0.007 pp | USD9.14 +35.2% | 5 qtrs — |
| 63 | PRUDENTIAL FINANCIAL INC | 89.9K -48.2K (-34.9%) | 1.11M -106.9K (-8.8%) | 0.17% -0.086 pp | 0.00% 0.000 pp | USD8.82 +40.1% | 65 qtrs — |
| 64 | RAFFERTY ASSET MANAGEMENT, LLC | 89.0K -5.2K (-5.5%) | 1.10M +269.2K (+32.4%) | 0.17% -0.007 pp | 0.00% +0.001 pp | USD8.44 +46.4% | 6 qtrs — |
| 65 | LPL FINANCIAL LLC | 80.1K +47.9K (+149.0%) | 990.0K +706.3K (+249.0%) | 0.15% +0.091 pp | 0.00% +0.000 pp | USD10.90 +13.4% | 6 qtrs — |
| 66 | FRANKLIN RESOURCES INC | 78.9K +1.8K (+2.3%) | 975.8K +295.0K (+43.3%) | 0.15% +0.006 pp | 0.00% +0.000 pp | USD8.90 +38.9% | 2 qtrs — |
| 67 | LOS ANGELES CAPITAL MANAGEMENT LLC | 70.9K -64.0K (-47.4%) | 910.6K -279.2K (-23.5%) | 0.13% -0.116 pp | 0.00% -0.001 pp | USD8.82 +40.1% | 2 qtrs — |
| 68 | WELLS FARGO & COMPANY/MN | 69.2K +17.1K (+32.8%) | 855.4K +395.9K (+86.1%) | 0.13% +0.034 pp | 0.00% +0.000 pp | USD8.32 +48.6% | 57 qtrs — |
| 69 | RHUMBLINE ADVISERS | 68.7K -12.2K (-15.1%) | 848.7K +135.5K (+19.0%) | 0.13% -0.020 pp | 0.00% +0.000 pp | USD9.75 +26.8% | 52 qtrs — |
| 70 | JAMES INVESTMENT RESEARCH INC | 61.9K +61.9K (+100.0%) | 765.1K +765.1K (+100.0%) | 0.12% +0.116 pp | 0.08% +0.084 pp | USD12.36 +0.0% | 1 qtrs NEW |
| 71 | BNP PARIBAS ARBITRAGE, SNC | 60.4K +49.4K (+451.6%) | 746.1K +649.6K (+673.1%) | 0.11% +0.093 pp | 0.00% +0.000 pp | USD11.41 +8.3% | 49 qtrs — |
| 72 | MARTINGALE ASSET MANAGEMENT L P | 57.8K +886.0 (+1.6%) | 715.0K +212.6K (+42.3%) | 0.11% +0.004 pp | 0.02% +0.006 pp | USD8.87 +39.3% | 2 qtrs — |
| 73 | ASSENAGON ASSET MANAGEMENT S.A. | 57.8K +1.4K (+2.4%) | 714.5K +216.5K (+43.5%) | 0.11% +0.005 pp | 0.00% +0.000 pp | USD5.62 +119.9% | 19 qtrs — |
| 74 | ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 54.8K +21.1K (+62.7%) | 677.8K +380.5K (+128.0%) | 0.10% +0.041 pp | 0.00% +0.000 pp | USD10.18 +21.4% | 2 qtrs — |
| 75 | ALLIANCEBERNSTEIN L.P. | 52.1K +33.0K (+172.9%) | 643.5K +475.2K (+282.4%) | 0.10% +0.063 pp | 0.00% +0.000 pp | USD10.17 +21.5% | 3 qtrs — |
| 76 | SIERRA SUMMIT ADVISORS LLC | 48.5K +48.5K (+100.0%) | 599.0K +599.0K (+100.0%) | 0.09% +0.091 pp | 0.09% +0.092 pp | USD12.36 +0.0% | 1 qtrs NEW |
| 77 | TWO SIGMA ADVISERS, LP | 45.4K +2.2K (+5.1%) | 561.1K +180.1K (+47.3%) | 0.09% +0.006 pp | 0.00% +0.000 pp | USD13.63 -9.3% | 19 qtrs — |
| 78 | JUMP FINANCIAL, LLC | 42.1K -271.9K (-86.6%) | 520.9K -2.2M (-81.2%) | 0.08% -0.500 pp | 0.01% -0.027 pp | USD8.39 +47.3% | 11 qtrs — |
| 79 | HARBOR CAPITAL ADVISORS, INC. | 40.9K +19.7K (+93.0%) | 505.0K +318.0K (+170.1%) | 0.08% +0.038 pp | 0.04% +0.025 pp | USD8.47 +45.9% | 4 qtrs — |
| 80 | SG AMERICAS SECURITIES, LLC | 40.5K +25.2K (+164.5%) | 501.0K +366.0K (+271.1%) | 0.08% +0.048 pp | 0.00% +0.000 pp | USD11.02 +12.2% | 2 qtrs — |
| 81 | ADVISORSHARES INVESTMENTS LLC | 39.9K +39.9K (+100.0%) | 493.2K +493.2K (+100.0%) | 0.08% +0.075 pp | 0.08% +0.082 pp | USD12.36 +0.0% | 1 qtrs NEW |
| 82 | PRICE T ROWE ASSOCIATES INC /MD/ | 39.0K -1.5K (-3.6%) | 482.0K +125.0K (+35.0%) | 0.07% -0.001 pp | 0.00% +0.000 pp | USD7.05 +75.3% | 38 qtrs — |
| 83 | WEISS ASSET MANAGEMENT LP | 37.8K +37.8K (+100.0%) | 467.0K +467.0K (+100.0%) | 0.07% +0.071 pp | 0.01% +0.007 pp | USD12.36 +0.0% | 1 qtrs NEW |
| 84 | PROFUND ADVISORS LLC | 33.1K +12.7K (+62.1%) | 409.2K +229.0K (+127.1%) | 0.06% +0.025 pp | 0.01% +0.007 pp | USD9.94 +24.3% | 6 qtrs — |
| 85 | IEQ CAPITAL, LLC | 31.9K -2.4K (-7.1%) | 393.8K +91.2K (+30.1%) | 0.06% -0.003 pp | 0.00% +0.000 pp | USD8.82 +40.1% | 2 qtrs — |
| 86 | METLIFE INVESTMENT MANAGEMENT, LLC | 31.4K +5.0K (+18.9%) | 388.3K +155.2K (+66.6%) | 0.06% +0.010 pp | 0.00% +0.001 pp | USD7.33 +68.6% | 3 qtrs — |
| 87 | INTECH INVESTMENT MANAGEMENT LLC | 29.5K -4.5K (-13.2%) | 364.5K +64.8K (+21.6%) | 0.06% -0.007 pp | 0.00% +0.001 pp | USD6.76 +82.8% | 3 qtrs — |
| 88 | MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 29.4K -760.0 (-2.5%) | 362.9K +95.9K (+35.9%) | 0.06% 0.000 pp | 0.00% +0.000 pp | USD6.49 +90.4% | 7 qtrs — |
| 89 | WINTON GROUP LTD | 29.1K +8.7K (+42.5%) | 359.6K +179.6K (+99.7%) | 0.05% +0.017 pp | 0.01% +0.006 pp | USD9.88 +25.1% | 2 qtrs — |
| 90 | KEYSTONE FINANCIAL GROUP | 29.1K -2.2K (-7.0%) | 359.5K +83.7K (+30.3%) | 0.05% -0.003 pp | 0.03% +0.006 pp | USD5.54 +123.1% | 4 qtrs — |
| 91 | AQUATIC CAPITAL MANAGEMENT LLC | 28.8K +18.1K (+170.4%) | 355.4K +261.6K (+279.0%) | 0.05% +0.034 pp | 0.01% +0.008 pp | USD10.17 +21.5% | 6 qtrs — |
| 92 | CREATIVE PLANNING | 28.5K +6.8K (+31.3%) | 352.9K +161.1K (+84.0%) | 0.05% +0.014 pp | 0.00% +0.000 pp | USD6.82 +81.2% | 8 qtrs — |
| 93 | RAYMOND JAMES FINANCIAL INC | 28.3K +28.3K (+100.0%) | 349.6K +349.6K (+100.0%) | 0.05% +0.053 pp | 0.00% +0.000 pp | USD12.36 +0.0% | 3 qtrs — |
| 94 | ARISTEIA CAPITAL LLC | 27.9K +27.9K (+100.0%) | 345.5K +345.5K (+100.0%) | 0.05% +0.053 pp | 0.01% +0.008 pp | USD12.36 +0.0% | 8 qtrs — |
Ownership breakdown by holder
ETF Ownership
Top ETFs holding this stock
Held by 106 ETFs in our universe
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | BondBloxx CCC Rated USD High Yield Corporate Bond ETF XCCC | 0.42% | 1.10M | 0.40% |
| 2 | State Street SPDR Portfolio Europe ETF SPEU | 0.25% | 1.77M | 0.07% |
| 3 | State Street SPDR MSCI EAFE Fossil Fuel Reserves Free ETF EFAX | 0.20% | 1.00M | 0.20% |
| 4 | Royce Quant Small-Cap Quality Value ETF SQLV | 0.19% | 55.6K | 0.60% |
| 5 | State Street SPDR MSCI ACWI ex-US ETF CWI | 0.18% | 5.10M | 0.30% |
| 6 | Federated Hermes MDT Small Cap Core ETF FSCC | 0.16% | 266.9K | 0.51% |
| 7 | State Street SPDR Portfolio Developed World ex-US ETF SPDW | 0.14% | 56.73M | 0.03% |
| 8 | First Trust Active Factor Small Cap ETF AFSM | 0.14% | 158.5K | 0.75% |
| 9 | WisdomTree International Efficient Core Fund NTSI | 0.14% | 680.7K | 0.26% |
| 10 | John Hancock Investments - Multifactor Developed International ETF JHMD | 0.14% | 1.29M | 0.43% |
Insider Activity
Insider Activity — Latest Quarter
Ratio by transactions
7.00
Bullish
Ratio by volume
3.00
Bullish
Buys
7
Sells
1
Shares acquired
855.1K
Shares disposed
4.0K
Cash buys
—
Cash sales
1.00
Net activity
+851,114
Insider buys vs sells (history)
From
To
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-04-29 | Williams Paul Anthony | Officer | A-Award | A | Common Stock | 100,111 | 0.00 | — | 162,792 | D | ↗ |
| 2026-04-29 | Perl Jessica | Officer | A-Award | A | Common Stock | 104,282 | 0.00 | — | 165,286 | D | ↗ |
| 2026-04-29 | PAPA JOSEPH C | Director / Officer | A-Award | A | Common Stock | 187,708 | 0.00 | — | 493,153 | D | ↗ |
| 2026-04-29 | Lowry Simon C | Officer | A-Award | A | Common Stock | 100,111 | 0.00 | — | 177,914 | D | ↗ |
| 2026-04-29 | LINDAHL RICHARD S | Officer | A-Award | A | Common Stock | 162,680 | 0.00 | — | 378,047 | D | ↗ |
| 2026-04-29 | Hartzel William | Officer | A-Award | A | Common Stock | 100,111 | 0.00 | — | 187,299 | D | ↗ |
| 2026-04-29 | Glessner Coleen | Officer | A-Award | A | Common Stock | 100,111 | 0.00 | — | 204,219 | D | ↗ |
| 2026-04-01 | Williams Paul Anthony | Officer | S-Sale | D | Common Stock | 4,000 | 8.44 | 33.8K | 62,681 | D | ↗ |
| 2026-03-05 | Williams Paul Anthony | Officer | F-InKind | D | Common Stock | 9,397 | 8.44 | 79.3K | 66,681 | D | ↗ |
| 2026-03-05 | Perl Jessica | Officer | F-InKind | D | Common Stock | 6,465 | 8.44 | 54.6K | 61,004 | D | ↗ |
| 2026-03-05 | PAPA JOSEPH C | Director / Officer | F-InKind | D | Common Stock | 37,055 | 8.44 | 312.7K | 305,445 | D | ↗ |
| 2026-03-05 | Lowry Simon C | Officer | F-InKind | D | Common Stock | 10,636 | 8.44 | 89.8K | 77,803 | D | ↗ |
| 2026-03-05 | LINDAHL RICHARD S | Officer | F-InKind | D | Common Stock | 23,650 | 8.44 | 199.6K | 215,367 | D | ↗ |
| 2026-03-05 | Hartzel William | Officer | F-InKind | D | Common Stock | 9,493 | 8.44 | 80.1K | 87,188 | D | ↗ |
| 2026-03-05 | Glessner Coleen | Officer | F-InKind | D | Common Stock | 8,199 | 8.44 | 69.2K | 104,108 | D | ↗ |
| 2026-03-03 | Williams Paul Anthony | Officer | A-Award | A | Employee Stock Option (Right to buy) | 44,834 | 8.99 | 403.1K | 254,948 | D | ↗ |
| 2026-03-03 | Perl Jessica | Officer | A-Award | A | Employee Stock Option (Right to buy) | 46,702 | 8.99 | 419.9K | 142,647 | D | ↗ |
| 2026-03-03 | PAPA JOSEPH C | Director / Officer | A-Award | A | Employee Stock Option (Right to buy) | 252,194 | 8.99 | 2.27M | 1,784,694 | D | ↗ |
| 2026-03-03 | Lowry Simon C | Officer | A-Award | A | Employee Stock Option (Right to buy) | 44,834 | 8.99 | 403.1K | 147,833 | D | ↗ |
| 2026-03-03 | LINDAHL RICHARD S | Officer | A-Award | A | Employee Stock Option (Right to buy) | 72,856 | 8.99 | 655.0K | 557,346 | D | ↗ |
| 2026-03-03 | Hartzel William | Officer | A-Award | A | Employee Stock Option (Right to buy) | 44,834 | 8.99 | 403.1K | 259,545 | D | ↗ |
| 2026-03-03 | Glessner Coleen | Officer | A-Award | A | Employee Stock Option (Right to buy) | 44,834 | 8.99 | 403.1K | 294,447 | D | ↗ |
| 2026-03-03 | FOWLER JOHN D JR | Director | A-Award | A | Common Stock | 5,006 | 8.99 | 45.0K | 5,006 | D | ↗ |
| 2026-03-01 | LINDAHL RICHARD S | Officer | F-InKind | D | Common Stock | 683 | 8.15 | 5.6K | 239,017 | D | ↗ |
| 2026-03-01 | FOWLER JOHN D JR | Director | — | — | Common Stock | 0 | 0.00 | — | 0 | D | ↗ |
| 2026-02-25 | LINDAHL RICHARD S | Officer | H-ExpireLong | D | Employee Stock Option (Right to buy) | 20,321 | 61.01 | 1.24M | 0 | D | ↗ |
| 2026-02-09 | Perl Jessica | Officer | F-InKind | D | Common Stock | 918 | 11.03 | 10.1K | 67,469 | D | ↗ |
| 2026-02-06 | Williams Paul Anthony | Officer | F-InKind | D | Common Stock | 1,022 | 10.92 | 11.2K | 76,194 | D | ↗ |
| 2026-02-06 | LINDAHL RICHARD S | Officer | F-InKind | D | Common Stock | 5,642 | 10.92 | 61.6K | 239,700 | D | ↗ |
| 2026-02-06 | Hartzel William | Officer | F-InKind | D | Common Stock | 630 | 10.92 | 6.9K | 96,681 | D | ↗ |
| 2026-02-06 | Glessner Coleen | Officer | D-Return | D | Common Stock | 28,847 | 10.92 | 315.0K | 115,472 | D | ↗ |
| 2025-12-14 | Lowry Simon C | Officer | F-InKind | D | Common Stock | 3,543 | 11.41 | 40.4K | 88,439 | D | ↗ |
| 2025-12-05 | Richard Ronald | Director | F-InKind | D | Common Stock | 10,864 | 11.90 | 129.3K | 113,301 | D | ↗ |
| 2025-11-11 | Hartzel William | Officer | F-InKind | D | Common Stock | 610 | 10.88 | 6.6K | 103,082 | D | ↗ |
| 2025-11-10 | DeGolyer Donald W | Director | S-Sale | D | Common Stock | 17,801 | 10.54 | 187.6K | 119,858 | D | ↗ |
| 2025-11-07 | Dayal Sujata Tyagi | Director | S-Sale | D | Common Stock | 8,552 | 10.00 | 85.5K | 88,980 | D | ↗ |
| 2025-10-15 | LINDAHL RICHARD S | Officer | F-InKind | D | Common Stock | 4,995 | 9.60 | 48.0K | 291,497 | D | ↗ |
| 2025-10-07 | Glessner Coleen | Officer | S-Sale | D | Common Stock | 30,608 | 10.00 | 306.1K | 144,319 | D | ↗ |
| 2025-08-15 | Zoon Kathryn C | Director | S-Sale | D | Common Stock | 7,086 | 8.87 | 62.9K | 71,799 | D | ↗ |
| 2025-08-12 | DeGolyer Donald W | Director | S-Sale | D | Common Stock | 7,844 | 8.65 | 67.8K | 137,659 | D | ↗ |
| 2025-07-11 | Hartzel William | Officer | F-InKind | D | Common Stock | 4,263 | 7.36 | 31.4K | 103,692 | D | ↗ |
| 2025-06-08 | Williams Paul Anthony | Officer | F-InKind | D | Common Stock | 464 | 6.63 | 3.1K | 85,871 | D | ↗ |
| 2025-06-08 | LINDAHL RICHARD S | Officer | F-InKind | D | Common Stock | 2,733 | 6.63 | 18.1K | 296,492 | D | ↗ |
| 2025-06-08 | Hartzel William | Officer | F-InKind | D | Common Stock | 1,167 | 6.63 | 7.7K | 107,955 | D | ↗ |
| 2025-06-08 | Glessner Coleen | Officer | F-InKind | D | Common Stock | 1,249 | 6.63 | 8.3K | 174,927 | D | ↗ |
| 2025-05-23 | Katkin Keith | Director | S-Sale | D | Common Stock | 7,844 | 6.30 | 49.4K | 86,431 | D | ↗ |
| 2025-05-13 | PAPA JOSEPH C | Director / Officer | P-Purchase | A | Common Stock | 60,000 | 5.83 | 349.8K | 342,500 | D | ↗ |
| 2025-05-07 | LINDAHL RICHARD S | Officer | H-ExpireLong | D | Employee Stock Option (Right to buy) | 19,963 | 48.33 | 964.8K | 0 | D | ↗ |
| 2025-04-30 | Zoon Kathryn C | Director | A-Award | A | Stock Option (Right to Buy) | 15,824 | 5.45 | 86.2K | 41,572 | D | ↗ |
| 2025-04-30 | White Marvin L | Director | A-Award | A | Stock Option (Right to Buy) | 15,824 | 5.45 | 86.2K | 41,572 | D | ↗ |
| 2025-04-30 | SULLIVAN LOUIS W | Director | A-Award | A | Common Stock | 34,403 | 0.00 | — | 139,098 | D | ↗ |
| 2025-04-30 | Richard Ronald | Director | A-Award | A | Stock Option (Right to Buy) | 15,824 | 5.45 | 86.2K | 41,572 | D | ↗ |
| 2025-04-30 | Katkin Keith | Director | A-Award | A | Stock Option (Right to Buy) | 15,824 | 5.45 | 86.2K | 41,572 | D | ↗ |
| 2025-04-30 | Harsanyi Zsolt | Director / Officer | A-Award | A | Stock Option (Right to Buy) | 15,824 | 5.45 | 86.2K | 41,572 | D | ↗ |
| 2025-04-30 | Fowler Neal Franklin | Director | A-Award | A | Stock Option (Right to Buy) | 15,824 | 5.45 | 86.2K | 41,572 | D | ↗ |
| 2025-04-30 | DeGolyer Donald W | Director | A-Award | A | Stock Option (Right to Buy) | 15,824 | 5.45 | 86.2K | 41,572 | D | ↗ |
| 2025-04-30 | Dayal Sujata Tyagi | Director | A-Award | A | Common Stock | 34,403 | 0.00 | — | 97,532 | D | ↗ |
| 2025-04-07 | Hartzel William | Officer | F-InKind | D | Common Stock | 561 | 4.44 | 2.5K | 109,122 | D | ↗ |
| 2025-04-07 | Glessner Coleen | Officer | F-InKind | D | Common Stock | 480 | 4.44 | 2.1K | 176,176 | D | ↗ |
| 2025-03-12 | Zoon Kathryn C | Director | S-Sale | D | Common Stock | 10,000 | 5.73 | 57.3K | 44,482 | D | ↗ |
| 2025-03-12 | PAPA JOSEPH C | Director / Officer | A-Award | A | Employee Stock Options (Right to Buy) | 250,000 | 2.33 | 582.5K | 1,532,500 | D | ↗ |
| 2025-03-12 | Fowler Neal Franklin | Director | S-Sale | D | Common Stock | 35,000 | 5.83 | 204.1K | 101,100 | D | ↗ |
| 2025-03-06 | Williams Paul Anthony | Officer | A-Award | A | Common Stock | 62,500 | 0.00 | — | 86,335 | D | ↗ |
| 2025-03-06 | Perl Jessica | Officer | A-Award | A | Common Stock | 62,500 | 0.00 | — | 68,387 | D | ↗ |
| 2025-03-06 | PAPA JOSEPH C | Director / Officer | A-Award | A | Common Stock | 282,500 | 0.00 | — | 282,500 | D | ↗ |
| 2025-03-06 | Lowry Simon C | Officer | A-Award | A | Employee Stock Options (Right to Buy) | 62,500 | 5.80 | 362.5K | 102,999 | D | ↗ |
| 2025-03-06 | LINDAHL RICHARD S | Officer | A-Award | A | Common Stock | 146,888 | 0.00 | — | 299,225 | D | ↗ |
| 2025-03-06 | Hartzel William | Officer | A-Award | A | Common Stock | 62,500 | 0.00 | — | 109,975 | D | ↗ |
| 2025-03-06 | Glessner Coleen | Officer | A-Award | A | Common Stock | 62,500 | 0.00 | — | 176,656 | D | ↗ |
| 2025-03-05 | Hartzel William | Officer | F-InKind | D | Common Stock | 292 | 5.80 | 1.7K | 47,183 | D | ↗ |
| 2025-03-01 | Williams Paul Anthony | Officer | F-InKind | D | Common Stock | 116 | 7.48 | 867.68 | 23,835 | D | ↗ |
| 2025-03-01 | LINDAHL RICHARD S | Officer | F-InKind | D | Common Stock | 683 | 7.48 | 5.1K | 152,337 | D | ↗ |
| 2025-03-01 | Glessner Coleen | Officer | F-InKind | D | Common Stock | 313 | 7.48 | 2.3K | 114,156 | D | ↗ |
| 2025-02-28 | Williams Paul Anthony | Officer | F-InKind | D | Common Stock | 382 | 7.48 | 2.9K | 23,951 | D | ↗ |
| 2025-02-28 | LINDAHL RICHARD S | Officer | F-InKind | D | Common Stock | 1,073 | 7.48 | 8.0K | 153,020 | D | ↗ |
| 2025-02-12 | LINDAHL RICHARD S | Officer | D-Return | D | Common Stock | 16,916 | 0.00 | — | 154,093 | D | ↗ |
| 2025-02-12 | Glessner Coleen | Officer | D-Return | D | Common Stock | 24,078 | 0.00 | — | 114,469 | D | ↗ |
| 2025-02-09 | Perl Jessica | Officer | F-InKind | D | Common Stock | 918 | 10.00 | 9.2K | 5,887 | D | ↗ |
| 2024-12-15 | Lowry Simon C | Officer | A-Award | A | Employee Stock Option (Right to buy) | 40,499 | 8.48 | 343.4K | 40,499 | D | ↗ |
| 2024-12-08 | Glessner Coleen | Officer | F-InKind | D | Common Stock | 18,674 | 9.01 | 168.3K | 144,460 | D | ↗ |
| 2024-11-18 | Lowry Simon C | Officer | — | — | Common Stock | 0 | 0.00 | — | 0 | D | ↗ |
| 2024-11-12 | DeGolyer Donald W | Director | S-Sale | D | Common Stock | 25,000 | 10.91 | 272.8K | 111,100 | D | ↗ |
| 2024-11-11 | White Marvin L | Director | S-Sale | D | Common Stock | 14,287 | 11.97 | 171.0K | 54,092 | D | ↗ |
| 2024-11-11 | Hartzel William | Officer | F-InKind | D | Common Stock | 632 | 11.97 | 7.6K | 47,475 | D | ↗ |
| 2024-10-29 | Perl Jessica | Officer | — | — | Employee Stock Option (Right to buy) | 15,445 | 12.95 | 200.0K | 0 | D | ↗ |
| 2024-10-15 | LINDAHL RICHARD S | Officer | A-Award | A | Common Stock | 15,000 | 0.00 | — | 171,009 | D | ↗ |
| 2024-07-11 | Hartzel William | Officer | A-Award | A | Common Stock | 15,000 | 0.00 | — | 48,107 | — | ↗ |
| 2024-07-11 | Fox Jennifer Lynne | Officer | A-Award | A | Common Stock | 15,000 | 0.00 | — | 186,382 | — | ↗ |
| 2024-07-08 | Williams Paul Anthony | Officer | F-InKind | D | Common Stock | 85 | 8.13 | 691.05 | 24,333 | — | ↗ |
| 2024-06-08 | Williams Paul Anthony | Officer | F-InKind | D | Common Stock | 464 | 6.19 | 2.9K | 24,418 | — | ↗ |
| 2024-06-08 | LINDAHL RICHARD S | Officer | F-InKind | D | Common Stock | 2,733 | 6.19 | 16.9K | 156,009 | — | ↗ |
| 2024-06-08 | Hartzel William | Officer | F-InKind | D | Common Stock | 1,167 | 6.19 | 7.2K | 33,107 | — | ↗ |
| 2024-06-08 | Glessner Coleen | Officer | F-InKind | D | Common Stock | 1,249 | 6.19 | 7.7K | 163,134 | — | ↗ |
| 2024-06-08 | Fox Jennifer Lynne | Officer | F-InKind | D | Common Stock | 2,376 | 6.19 | 14.7K | 171,382 | — | ↗ |
| 2024-06-04 | Zoon Kathryn C | Director | S-Sale | D | Common Stock | 10,000 | 6.11 | 61.1K | 54,482 | — | ↗ |
| 2024-05-29 | Zoon Kathryn C | Director | S-Sale | D | Common Stock | 1,830 | 4.61 | 8.4K | 64,482 | — | ↗ |
| 2024-05-23 | Zoon Kathryn C | Director | A-Award | A | Stock Option (Right to Buy) | 25,748 | 5.02 | 129.3K | 25,748 | — | ↗ |
| 2024-05-23 | White Marvin L | Director | A-Award | A | Stock Option (Right to Buy) | 25,748 | 5.02 | 129.3K | 25,748 | — | ↗ |
| 2024-05-23 | SULLIVAN LOUIS W | Director | A-Award | A | Stock Option (Right to Buy) | 25,748 | 5.02 | 129.3K | 25,748 | — | ↗ |
| 2024-05-23 | Richard Ronald | Director | A-Award | A | Stock Option (Right to Buy) | 25,748 | 5.02 | 129.3K | 25,748 | — | ↗ |
| 2024-05-23 | Katkin Keith | Director | A-Award | A | Common Stock | 17,430 | 0.00 | — | 59,872 | — | ↗ |
| 2024-05-23 | Harsanyi Zsolt | Director / Officer | A-Award | A | Stock Option (Right to Buy) | 25,748 | 5.02 | 129.3K | 25,748 | — | ↗ |
| 2024-05-23 | Fowler Neal Franklin | Director | A-Award | A | Stock Option (Right to Buy) | 25,748 | 5.02 | 129.3K | 25,748 | — | ↗ |
| 2024-05-23 | DeGolyer Donald W | Director | A-Award | A | Stock Option (Right to Buy) | 25,748 | 5.02 | 129.3K | 25,748 | — | ↗ |
| 2024-05-23 | Dayal Sujata Tyagi | Director | A-Award | A | Stock Option (Right to Buy) | 25,748 | 5.02 | 129.3K | 25,748 | — | ↗ |
| 2024-05-21 | Zoon Kathryn C | Director | S-Sale | D | Common Stock | 1,089 | 5.78 | 6.3K | 48,882 | — | ↗ |
| 2024-04-07 | Hartzel William | Officer | F-InKind | D | Common Stock | 665 | 2.29 | 1.5K | 34,274 | — | ↗ |
| 2024-04-07 | Glessner Coleen | Officer | F-InKind | D | Common Stock | 585 | 2.29 | 1.3K | 164,383 | — | ↗ |
| 2024-03-13 | Williams Paul Anthony | Officer | A-Award | A | Employee Stock Options (Right to Buy) | 125,000 | 2.33 | 291.3K | 147,614 | — | ↗ |
| 2024-03-13 | PAPA JOSEPH C | Director / Officer | A-Award | A | Employee Stock Options (Right to Buy) | 750,000 | 2.33 | 1.75M | 750,000 | — | ↗ |
| 2024-03-13 | LINDAHL RICHARD S | Officer | A-Award | A | Employee Stock Options (Right to Buy) | 125,000 | 2.33 | 291.3K | 305,944 | — | ↗ |
| 2024-03-13 | Hartzel William | Officer | A-Award | A | Employee Stock Options (Right to Buy) | 125,000 | 2.33 | 291.3K | 152,211 | — | ↗ |
| 2024-03-13 | Glessner Coleen | Officer | A-Award | A | Employee Stock Options (Right to Buy) | 125,000 | 2.33 | 291.3K | 187,113 | — | ↗ |
| 2024-03-13 | Fox Jennifer Lynne | Officer | A-Award | A | Employee Stock Options (Right to Buy) | 125,000 | 2.33 | 291.3K | 223,169 | — | ↗ |
| 2024-03-05 | Hartzel William | Officer | F-InKind | D | Common Stock | 346 | 3.41 | 1.2K | 34,939 | — | ↗ |
| 2024-03-01 | Williams Paul Anthony | Officer | F-InKind | D | Common Stock | 137 | 3.39 | 464.43 | 24,882 | — | ↗ |
| 2024-03-01 | LINDAHL RICHARD S | Officer | F-InKind | D | Common Stock | 684 | 3.39 | 2.3K | 158,742 | — | ↗ |
| 2024-03-01 | Glessner Coleen | Officer | F-InKind | D | Common Stock | 381 | 3.39 | 1.3K | 164,968 | — | ↗ |
| 2024-03-01 | Fox Jennifer Lynne | Officer | F-InKind | D | Common Stock | 703 | 3.39 | 2.4K | 173,758 | — | ↗ |
| 2024-02-29 | Williams Paul Anthony | Officer | F-InKind | D | Common Stock | 450 | 3.23 | 1.5K | 25,019 | — | ↗ |
| 2024-02-29 | LINDAHL RICHARD S | Officer | F-InKind | D | Common Stock | 9,037 | 3.23 | 29.2K | 159,426 | — | ↗ |
| 2024-02-29 | Fox Jennifer Lynne | Officer | F-InKind | D | Common Stock | 4,103 | 3.23 | 13.3K | 174,461 | — | ↗ |
| 2024-02-23 | Williams Paul Anthony | Officer | F-InKind | D | Common Stock | 105 | 2.74 | 287.70 | 25,469 | — | ↗ |
| 2024-02-23 | LINDAHL RICHARD S | Officer | F-InKind | D | Common Stock | 517 | 2.74 | 1.4K | 168,463 | — | ↗ |
| 2024-02-23 | Fox Jennifer Lynne | Officer | F-InKind | D | Common Stock | 229 | 2.74 | 627.46 | 178,564 | — | ↗ |
| 2024-02-21 | PAPA JOSEPH C | Director / Officer | — | D | Common Stock | 0 | 0.00 | — | 0 | — | ↗ |
| 2024-02-21 | LINDAHL RICHARD S | Officer | D-Return | D | Common Stock | 4,012 | 2.71 | 10.9K | 168,980 | — | ↗ |
| 2023-11-13 | Williams Paul Anthony | Officer | F-InKind | D | Common Stock | 566 | 1.82 | 1.0K | 25,574 | — | ↗ |
| 2023-11-11 | Hartzel William | Officer | F-InKind | D | Common Stock | 632 | 2.00 | 1.3K | 35,285 | — | ↗ |
| 2023-11-11 | Fox Jennifer Lynne | Officer | F-InKind | D | Common Stock | 413 | 2.00 | 826.00 | 178,793 | — | ↗ |
| 2023-10-03 | Fowler Neal Franklin | Director | A-Award | A | Common Stock | 118,670 | 0.00 | — | 118,670 | — | ↗ |
| 2023-10-03 | DeGolyer Donald W | Director | A-Award | A | Common Stock | 118,670 | 0.00 | — | 118,670 | — | ↗ |
| 2023-10-01 | Fowler Neal Franklin | Director | — | D | Common Stock | 0 | 0.00 | — | 0 | — | ↗ |
| 2023-10-01 | DeGolyer Donald W | Director | — | D | Common Stock | 0 | 0.00 | — | 0 | — | ↗ |
| 2023-08-08 | Hartzel William | Officer | — | D | Employee Stock Options (Right to Buy) | 3,077 | 11.66 | 35.9K | 0 | — | ↗ |
| 2023-07-08 | Williams Paul Anthony | Officer | F-InKind | D | Common Stock | 85 | 0.00 | — | 26,140 | — | ↗ |
| 2023-06-24 | MILLER H HAYWOOD III | Officer | — | D | Common Stock | 0 | 0.00 | — | 0 | — | ↗ |
| 2023-06-09 | Williams Paul Anthony | Officer | A-Award | A | Common Stock | 4,616 | 0.00 | — | 16,994 | — | ↗ |
| 2023-06-09 | LINDAHL RICHARD S | Officer | A-Award | A | Common Stock | 24,616 | 0.00 | — | 123,761 | — | ↗ |
| 2023-06-09 | Kramer Robert | Director / Officer | A-Award | A | Employee Stock Option (Right to buy) | 141,539 | 8.39 | 1.19M | 535,051 | — | ↗ |
| 2023-06-09 | Havey Adam | Officer | A-Award | A | Employee Stock Option (Right to buy) | 49,231 | 8.39 | 413.0K | 161,906 | — | ↗ |
| 2023-06-09 | Glessner Coleen | Officer | A-Award | A | Employee Stock Option (Right to buy) | 30,770 | 8.39 | 258.2K | 62,113 | — | ↗ |
| 2023-06-09 | Fox Jennifer Lynne | Officer | A-Award | A | Common Stock | 49,231 | 0.00 | — | 179,206 | — | ↗ |
| 2023-06-02 | Zoon Kathryn C | Director | S-Sale | D | Common Stock | 1,830 | 8.35 | 15.3K | 49,971 | — | ↗ |
| 2023-05-25 | Zoon Kathryn C | Director | S-Sale | D | Common Stock | 1,700 | 8.38 | 14.2K | 51,801 | — | ↗ |
| 2023-05-25 | White Marvin L | Director | A-Award | A | Common Stock | 33,847 | 0.00 | — | 50,949 | — | ↗ |
| 2023-05-25 | SULLIVAN LOUIS W | Director | A-Award | A | Common Stock | 33,847 | 0.00 | — | 87,265 | — | ↗ |
| 2023-05-25 | Richard Ronald | Director | A-Award | A | Common Stock | 33,847 | 0.00 | — | 53,684 | — | ↗ |
| 2023-05-25 | Katkin Keith | Director | A-Award | A | Common Stock | 33,847 | 0.00 | — | 42,442 | — | ↗ |
| 2023-05-25 | Hauer Jerome M | Director | A-Award | A | Common Stock | 33,847 | 0.00 | — | 57,508 | — | ↗ |
| 2023-05-25 | Harsanyi Zsolt | Director / Officer | A-Award | A | Common Stock | 33,847 | 0.00 | — | 71,899 | — | ↗ |
| 2023-05-25 | Dayal Sujata Tyagi | Director | A-Award | A | Common Stock | 33,847 | 0.00 | — | 45,699 | — | ↗ |
| 2023-04-07 | Glessner Coleen | Officer | F-InKind | A | Common Stock | 480 | 0.00 | — | 120,154 | — | ↗ |
| 2023-03-02 | Williams Paul Anthony | Officer | A-Award | A | Common Stock | 2,308 | 0.00 | — | 12,378 | — | ↗ |
| 2023-03-02 | LINDAHL RICHARD S | Officer | A-Award | A | Common Stock | 6,154 | 0.00 | — | 86,837 | — | ↗ |
| 2023-03-02 | Kramer Robert | Director / Officer | A-Award | A | Common Stock | 38,462 | 0.00 | — | 293,751 | — | ↗ |
| 2023-03-02 | Havey Adam | Officer | A-Award | A | Employee Stock Options (Right to Buy) | 12,308 | 12.06 | 148.4K | 112,675 | — | ↗ |
| 2023-03-02 | Glessner Coleen | Officer | A-Award | A | Employee Stock Options (Right to Buy) | 7,692 | 12.06 | 92.8K | 31,343 | — | ↗ |
| 2023-03-02 | Fox Jennifer Lynne | Officer | A-Award | A | Employee Stock Options (Right to Buy) | 12,308 | 12.06 | 148.4K | 48,938 | — | ↗ |
| 2023-02-28 | Williams Paul Anthony | Officer | F-InKind | D | Common Stock | 371 | 12.38 | 4.6K | 8,916 | — | ↗ |
| 2023-02-28 | Strei Katherine | Officer | F-InKind | D | Common Stock | 690 | 12.38 | 8.5K | 62,824 | — | ↗ |
| 2023-02-28 | SARAN ATUL | Officer | F-InKind | D | Common Stock | 971 | 12.38 | 12.0K | 86,645 | — | ↗ |
| 2023-02-28 | LINDAHL RICHARD S | Officer | F-InKind | D | Common Stock | 1,074 | 12.38 | 13.3K | 16,906 | — | ↗ |
| 2023-02-28 | Kramer Robert | Director / Officer | F-InKind | D | Common Stock | 3,226 | 12.38 | 39.9K | 103,298 | — | ↗ |
| 2023-02-28 | Havey Adam | Officer | F-InKind | D | Common Stock | 998 | 12.38 | 12.4K | 33,927 | — | ↗ |
| 2023-02-28 | Fox Jennifer Lynne | Officer | F-InKind | D | Common Stock | 1,005 | 12.38 | 12.4K | 86,897 | — | ↗ |
| 2023-02-24 | Strei Katherine | Officer | F-InKind | D | Common Stock | 654 | 13.71 | 9.0K | 63,514 | — | ↗ |
| 2023-02-24 | SARAN ATUL | Officer | F-InKind | D | Common Stock | 845 | 13.71 | 11.6K | 87,616 | — | ↗ |
| 2023-02-24 | LINDAHL RICHARD S | Officer | F-InKind | D | Common Stock | 977 | 13.71 | 13.4K | 17,980 | — | ↗ |
| 2023-02-24 | Kramer Robert | Director / Officer | F-InKind | D | Common Stock | 1,591 | 13.71 | 21.8K | 106,524 | — | ↗ |
| 2023-02-24 | Havey Adam | Officer | F-InKind | D | Common Stock | 812 | 13.71 | 11.1K | 33,681 | — | ↗ |
| 2023-02-24 | Fox Jennifer Lynne | Officer | F-InKind | D | Common Stock | 258 | 13.71 | 3.5K | 87,902 | — | ↗ |
| 2023-02-23 | Williams Paul Anthony | Officer | F-InKind | D | Common Stock | 89 | 14.30 | 1.3K | 9,287 | — | ↗ |
| 2023-02-23 | Strei Katherine | Officer | F-InKind | D | Common Stock | 352 | 14.30 | 5.0K | 64,168 | — | ↗ |
| 2023-02-23 | SARAN ATUL | Officer | F-InKind | D | Common Stock | 365 | 14.30 | 5.2K | 88,461 | — | ↗ |
| 2023-02-23 | LINDAHL RICHARD S | Officer | F-InKind | D | Common Stock | 444 | 14.30 | 6.3K | 18,957 | — | ↗ |
| 2023-02-23 | Kramer Robert | Director / Officer | F-InKind | D | Common Stock | 1,428 | 14.30 | 20.4K | 108,115 | — | ↗ |
| 2023-02-23 | Havey Adam | Officer | F-InKind | D | Common Stock | 432 | 14.30 | 6.2K | 34,493 | — | ↗ |
| 2023-02-23 | Fox Jennifer Lynne | Officer | F-InKind | D | Common Stock | 231 | 14.30 | 3.3K | 88,160 | — | ↗ |
| 2023-02-08 | Strei Katherine | Officer | A-Award | A | Common Stock | 61 | 0.00 | — | 65,958 | — | ↗ |
| 2023-02-08 | SARAN ATUL | Officer | F-InKind | D | Common Stock | 2,051 | 13.25 | 27.2K | 88,826 | — | ↗ |
| 2023-02-08 | LINDAHL RICHARD S | Officer | A-Award | A | Common Stock | 101 | 0.00 | — | 21,797 | — | ↗ |
| 2023-02-08 | Kramer Robert | Director / Officer | A-Award | A | Common Stock | 278 | 0.00 | — | 114,487 | — | ↗ |
| 2023-02-08 | Havey Adam | Officer | A-Award | A | Common Stock | 95 | 0.00 | — | 36,889 | — | ↗ |
| 2023-01-09 | Williams Paul Anthony | Officer | — | D | Employee Stock Options (Right to Buy) | 7,613 | 41.38 | 315.0K | — | — | ↗ |
| 2022-12-09 | Glessner Coleen | Officer | A-Award | A | Common Stock | 72,232 | 0.00 | — | 108,136 | — | ↗ |
| 2022-12-09 | Fox Jennifer Lynne | Officer | A-Award | A | Common Stock | 14,045 | 0.00 | — | 46,256 | — | ↗ |
| 2022-11-25 | Richard Ronald | Director | S-Sale | D | Common Stock | 1,912 | 11.94 | 22.8K | 19,837 | — | ↗ |
| 2022-11-11 | Fox Jennifer Lynne | Officer | F-InKind | D | Common Stock | 416 | 15.00 | 6.2K | 32,211 | — | ↗ |
| 2022-07-21 | Dayal Sujata Tyagi | Director | A-Award | A | Common Stock | 11,852 | 0.00 | — | 11,852 | — | ↗ |
| 2022-07-15 | Dayal Sujata Tyagi | Director | — | D | Common Stock | 0 | 0.00 | — | 0 | — | ↗ |
| 2022-06-09 | Zoon Kathryn C | Director | S-Sale | D | Common Stock | 1,173 | 31.52 | 37.0K | 19,654 | — | ↗ |
| 2022-05-26 | Zoon Kathryn C | Director | A-Award | A | Common Stock | 8,446 | 0.00 | — | 20,827 | — | ↗ |
| 2022-05-26 | White Marvin L | Director | A-Award | A | Common Stock | 8,446 | 0.00 | — | 17,102 | — | ↗ |
| 2022-05-26 | SULLIVAN LOUIS W | Director | A-Award | A | Common Stock | 8,446 | 0.00 | — | 53,418 | — | ↗ |
| 2022-05-26 | Richard Ronald | Director | A-Award | A | Common Stock | 8,446 | 0.00 | — | 21,749 | — | ↗ |
| 2022-05-26 | JOULWAN GEORGE A | Director | A-Award | A | Common Stock | 8,446 | 0.00 | — | 40,244 | — | ↗ |
| 2022-05-26 | Hauer Jerome M | Director | A-Award | A | Common Stock | 8,446 | 0.00 | — | 23,661 | — | ↗ |
| 2022-05-26 | Harsanyi Zsolt | Director | A-Award | A | Common Stock | 8,446 | 0.00 | — | 38,052 | — | ↗ |
| 2022-05-24 | Zoon Kathryn C | Director | S-Sale | D | Common Stock | 1,996 | 35.53 | 70.9K | 12,381 | — | ↗ |
Executive team
Top executives
EBIT / Employee
122.4K
Shares Outstanding
51.64M
Executive compensation
Executive compensation (annual)
| # | Year | Executive | Salary | Bonus | Stock award | Option award | Incentive | Other | Total | % Stock- based |
Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2025 | Joseph Papa President, Chief Executive Officer and Director | 1.04M | — | 1.64M | 1.19M | 1.45M | 7.1K | 5.32M | 53.18% | ↗ |
| 2 | 2025 | Richard Lindahl Executive Vice President, Chief Financial Officer | 662.0K | — | 852.0K | 753.1K | 431.2K | 10.5K | 2.71M | 59.25% | ↗ |
| 3 | 2025 | Coleen Glessner Executive Vice President, Quality and Ethics and Compliance | 623.6K | — | 362.5K | 263.6K | 406.1K | 8.5K | 1.66M | 37.62% | ↗ |
| 4 | 2025 | Simon Lowry Chief Medical Officer and Head of Research and Development | 545.0K | — | 362.5K | 263.6K | 289.7K | 10.5K | 1.47M | 42.56% | ↗ |
| 5 | 2025 | Paul Williams Senior Vice President, Products Business | 495.0K | — | 362.5K | 263.6K | 262.6K | 7.4K | 1.39M | 45.01% | ↗ |
| 6 | 2024 | Joseph Papa President, Chief Executive Officer and Director | 800.0K | 1.00M | 516.0K | 1.97M | 1.57M | 7.0K | 5.86M | 42.46% | ↗ |
| 7 | 2024 | Richard Lindahl Executive Vice President, Chief Financial Officer and Treasurer | 638.2K | 799.5K | 135.0K | 187.2K | 541.1K | 10.4K | 2.31M | 13.94% | ↗ |
| 8 | 2024 | Richard Lindahl Executive Vice President, Chief Financial Officer | 638.2K | 799.5K | 135.0K | 187.2K | 541.1K | 10.4K | 2.31M | 13.94% | ↗ |
| 9 | 2024 | Coleen Glessner Executive Vice President, Quality and Ethics and Compliance | 602.1K | 747.5K | — | 187.2K | 507.2K | 9.2K | 2.05M | 9.12% | ↗ |
| 10 | 2024 | William Hartzel Senior Vice President, Manufacturing and Bioservices | 467.0K | 585.0K | 139.5K | 187.2K | 325.3K | 10.4K | 1.71M | 19.06% | ↗ |
| 11 | 2024 | Paul Williams Senior Vice President, Products Business | 469.6K | 685.0K | — | 187.2K | 325.9K | 8.1K | 1.68M | 11.17% | ↗ |
| 12 | 2024 | Jennifer Fox Former Executive Vice President, External Affairs, General Counsel and Corporate Secretary | 472.7K | 380.3K | 139.5K | 187.2K | — | 10.4K | 1.19M | 27.45% | ↗ |
| 13 | 2024 | Haywood Miller Former Interim Chief Executive Officer | 218.8K | — | — | — | — | — | 218.8K | 0.00% | ↗ |
| 14 | 2023 | Robert Kramer Former President, Chief Executive Officer and Director | 777.6K | — | 2.48M | 921.0K | — | 928.2K | 5.10M | 66.58% | ↗ |
| 15 | 2023 | Richard Lindahl Executive Vice President, Chief Financial Officer and Treasurer | 613.9K | 399.8K | 842.2K | 313.3K | — | 9.9K | 2.18M | 53.03% | ↗ |
| 16 | 2023 | Richard Lindahl Executive Vice President, Chief Financial Officer | 613.9K | 399.8K | 842.2K | 313.3K | — | 9.9K | 2.18M | 53.03% | ↗ |
| 17 | 2023 | Jennifer Fox Executive Vice President, External Affairs, General Counsel and Corporate Secretary | 585.7K | 380.3K | 842.2K | 313.3K | — | 9.9K | 2.13M | 54.21% | ↗ |
| 18 | 2023 | Jennifer Fox Former Executive Vice President, External Affairs, General Counsel and Corporate Secretary | 585.7K | 380.3K | 842.2K | 313.3K | — | 9.9K | 2.13M | 54.21% | ↗ |
| 19 | 2023 | Adam Havey Executive Vice President and Chief Operating Officer | 558.0K | — | 842.2K | 313.3K | — | 297.0K | 2.01M | 57.47% | ↗ |
| 20 | 2023 | Coleen Glessner Executive Vice President, Quality and Ethics and Compliance | 575.7K | 373.8K | 526.4K | 195.8K | — | 9.9K | 1.68M | 42.95% | ↗ |
| 21 | 2023 | Paul Williams Senior Vice President, Products Business | 445.8K | 392.5K | 157.9K | 58.7K | — | 8.7K | 1.06M | 20.37% | ↗ |
| 22 | 2023 | Haywood Miller Interim Chief Executive Officer | 766.7K | — | — | — | — | — | 766.7K | 0.00% | ↗ |
| 23 | 2023 | Haywood Miller Former Interim Chief Executive Officer | 766.7K | — | — | — | — | — | 766.7K | 0.00% | ↗ |
| 24 | 2022 | Robert Kramer Former President, Chief Executive Officer and Director | 1.03M | — | 3.70M | 2.53M | 309.8K | 6.3K | 7.58M | 82.23% | ↗ |
| 25 | 2022 | Robert Kramer President, Chief Executive Officer and Director | 1.03M | — | 3.70M | 2.53M | 309.8K | 6.3K | 7.58M | 82.23% | ↗ |
| 26 | 2022 | Adam Havey Executive Vice President and Chief Operating Officer | 574.8K | — | 2.08M | 791.2K | 172.8K | 7.8K | 3.62M | 79.14% | ↗ |
| 27 | 2022 | Richard Lindahl Executive Vice President, Chief Financial Officer and Treasurer | 593.9K | — | 2.00M | 723.4K | 196.4K | 9.2K | 3.52M | 77.31% | ↗ |
| 28 | 2022 | Atul Saran Former Executive Vice President and Chief Strategy and Development Officer | 574.8K | — | 2.00M | 723.4K | 198.4K | 8.3K | 3.50M | 77.70% | ↗ |
| 29 | 2022 | Jennifer Fox Former Executive Vice President, External Affairs, General Counsel and Corporate Secretary | 473.5K | — | 1.75M | 497.4K | 193.1K | 9.2K | 2.92M | 76.88% | ↗ |
| 30 | 2022 | Jennifer Fox Executive Vice President, External Affairs, General Counsel and Corporate Secretary | 473.5K | — | 1.75M | 497.4K | 193.1K | 9.2K | 2.92M | 76.88% | ↗ |
| 31 | 2021 | Robert Kramer Former President, Chief Executive Officer and Director | 1.03M | — | 2.80M | 2.20M | 900.0K | 6.4K | 6.93M | 72.11% | ↗ |
| 32 | 2021 | Robert Kramer President, Chief Executive Officer and Director | 1.03M | — | 2.80M | 2.20M | 900.0K | 6.4K | 6.93M | 72.11% | ↗ |
| 33 | 2021 | Fuad El-Hibri Former Executive Chairman of the Board of Directors | 1.19M | — | 1.30M | 1.02M | — | 4.3K | 3.52M | 66.01% | ↗ |
| 34 | 2021 | Richard Lindahl Executive Vice President, Chief Financial Officer and Treasurer | 577.4K | — | 750.1K | 588.9K | 272.6K | 8.7K | 2.20M | 60.93% | ↗ |
| 35 | 2021 | Adam Havey Executive Vice President and Chief Operating Officer | 574.3K | — | 700.1K | 549.6K | 261.4K | 7.4K | 2.09M | 59.71% | ↗ |
| 36 | 2021 | Atul Saran Former Executive Vice President and Chief Strategy and Development Officer | 553.9K | — | 700.1K | 549.6K | 258.1K | 8.7K | 2.07M | 60.36% | ↗ |
| 37 | 2021 | Atul Saran Executive Vice President and Chief Strategy and and Development Officer | 553.9K | — | 700.1K | 549.6K | 258.1K | 8.7K | 2.07M | 60.36% | ↗ |
| 38 | 2020 | Robert Kramer President and Chief Executive Officer | 893.9K | — | 2.05M | 1.39M | 1.23M | 8.7K | 5.57M | 61.80% | ↗ |
| 39 | 2020 | Robert Kramer President, Chief Executive Officer and Director | 893.9K | — | 2.05M | 1.39M | 1.23M | 8.7K | 5.57M | 61.80% | ↗ |
| 40 | 2020 | Fuad El-Hibri Former Executive Chairman of the Board of Directors | 1.19M | — | 1.20M | 815.1K | — | 6.2K | 3.21M | 62.71% | ↗ |
| 41 | 2020 | Fuad El-Hibri Executive Chairman of the Board of Directors | 1.19M | — | 1.20M | 815.1K | — | 6.2K | 3.21M | 62.71% | ↗ |
| 42 | 2020 | Richard Lindahl Executive Vice President, Chief Financial Officer and Treasurer | 549.4K | — | 750.0K | 509.4K | 462.0K | 10.5K | 2.28M | 55.21% | ↗ |
| 43 | 2020 | Richard Lindahl Executive Vice President, Chief Financial Officer and Treasurer | 549.4K | — | 750.0K | 509.4K | 462.0K | 10.5K | 2.28M | 55.21% | ↗ |
| 44 | 2020 | Adam Havey Executive Vice President and Chief Operating Officer | 546.5K | — | 700.0K | 475.4K | 445.2K | 8.4K | 2.18M | 54.03% | ↗ |
| 45 | 2020 | Adam Havey Executive Vice President, Business Operations | 546.5K | — | 700.0K | 475.4K | 445.2K | 8.4K | 2.18M | 54.03% | ↗ |
| 46 | 2020 | Atul Saran Executive Vice President and Chief Strategy and and Development Officer | 528.8K | — | 700.0K | 475.4K | 445.2K | 9.6K | 2.16M | 54.44% | ↗ |
| 47 | 2020 | Atul Saran Former Executive Vice President and Chief Strategy and Development Officer | 528.8K | — | 700.0K | 475.4K | 445.2K | 9.6K | 2.16M | 54.44% | ↗ |
| 48 | 2020 | Atul Saran Executive Vice President, Corporate Development, | 528.8K | — | 700.0K | 475.4K | 445.2K | 9.6K | 2.16M | 54.44% | ↗ |
| 49 | 2019 | Robert G. Kramer President and Chief Executive Officer | 678.0K | — | 1.44M | 1.01M | 557.1K | 5.7K | 3.69M | 66.41% | ↗ |
| 50 | 2019 | Robert Kramer President, Chief Executive Officer and Director | 678.0K | — | 1.44M | 1.01M | 557.1K | 5.7K | 3.69M | 66.41% | ↗ |
| 51 | 2019 | Robert Kramer President and Chief Executive Officer | 678.0K | — | 1.44M | 1.01M | 557.1K | 5.7K | 3.69M | 66.41% | ↗ |
| 52 | 2019 | Fuad El-Hibri Executive Chairman of the Board of Directors | 1.13M | — | 1.10M | 773.8K | — | 4.7K | 3.01M | 62.25% | ↗ |
| 53 | 2019 | Fuad El-Hibri Former Executive Chairman of the Board of Directors | 1.13M | — | 1.10M | 773.8K | — | 4.7K | 3.01M | 62.25% | ↗ |
| 54 | 2019 | Richard Lindahl Executive Vice President, Chief Financial Officer and Treasurer | 514.8K | — | 620.0K | 436.2K | 297.4K | 9.1K | 1.88M | 56.25% | ↗ |
| 55 | 2019 | Richard Lindahl Executive Vice President, Chief Financial Officer and Treasurer | 514.8K | — | 620.0K | 436.2K | 297.4K | 9.1K | 1.88M | 56.25% | ↗ |
| 56 | 2019 | Richard S. Lindahl Executive Vice President, | 514.8K | — | 620.0K | 436.2K | 297.4K | 9.1K | 1.88M | 56.25% | ↗ |
| 57 | 2019 | Atul Saran Executive Vice President, Corporate Development, | 503.8K | — | 620.0K | 436.2K | 293.6K | 9.5K | 1.86M | 56.69% | ↗ |
| 58 | 2019 | Atul Saran Executive Vice President and Chief Strategy and and Development Officer | 503.8K | — | 620.0K | 436.2K | 293.6K | 9.5K | 1.86M | 56.69% | ↗ |
| 59 | 2019 | Adam Havey Executive Vice President and Chief Operating Officer | 484.1K | — | 620.0K | 436.2K | 279.6K | 25.5K | 1.85M | 57.23% | ↗ |
| 60 | 2019 | Adam Havey Executive Vice President, Business Operations | 484.1K | — | 620.0K | 436.2K | 279.6K | 25.5K | 1.85M | 57.23% | ↗ |
| 61 | 2019 | Daniel J. Abdun-Nabi Former Chief Executive Officer | 300.2K | — | 100.0K | — | 195.4K | 37.7K | 633.3K | 15.79% | ↗ |
| 62 | 2018 | Daniel J. Abdun-Nabi Former Chief Executive Officer | 829.2K | — | 1.33M | 955.2K | 980.4K | 8.7K | 4.10M | 55.66% | ↗ |
| 63 | 2018 | Fuad El-Hibri Executive Chairman of the Board of Directors | 1.05M | — | 957.5K | 957.5K | — | 8.3K | 2.97M | 64.47% | ↗ |
| 64 | 2018 | Robert G. Kramer, Sr. President and Chief Executive Officer | 549.0K | — | 649.9K | 468.2K | 538.8K | 6.5K | 2.40M | 46.65% | ↗ |
| 65 | 2018 | Robert G. Kramer President and Chief Executive Officer | 549.0K | — | 649.9K | 650.0K | 538.8K | 9.0K | 2.40M | 54.24% | ↗ |
| 66 | 2018 | Robert Kramer President and Chief Executive Officer | 549.0K | — | 649.9K | 650.0K | 538.8K | 9.0K | 2.40M | 54.24% | ↗ |
| 67 | 2018 | Atul Saran Executive Vice President, | 488.7K | — | 527.5K | 379.6K | 293.6K | 8.7K | 1.85M | 49.13% | ↗ |
| 68 | 2018 | Richard S. Lindahl | 365.4K | — | 557.4K | 351.1K | 330.0K | 8.5K | 1.74M | 52.36% | ↗ |
| 69 | 2018 | Atul Saran Executive Vice President, Corporate Development, | 488.7K | — | 527.5K | 379.6K | 293.6K | 8.7K | 1.70M | 53.42% | ↗ |
| 70 | 2018 | Adam Havey Executive Vice President, Business Operations | 480.7K | — | 500.0K | 359.8K | 310.2K | 8.4K | 1.66M | 51.82% | ↗ |
| 71 | 2018 | Richard Lindahl Executive Vice President, Chief Financial Officer and Treasurer | 365.4K | — | 557.4K | 351.1K | 330.0K | 8.5K | 1.61M | 56.35% | ↗ |
| 72 | 2018 | Richard S. Lindahl Executive Vice President, | 365.4K | — | 557.4K | 351.1K | 330.0K | 8.5K | 1.61M | 56.35% | ↗ |
| 73 | 2017 | Daniel J. Abdun-Nabi President and Chief Executive Officer | 819.0K | — | 1.20M | 847.1K | 806.2K | 9.0K | 3.68M | 55.61% | ↗ |
| 74 | 2017 | Daniel J. Abdun-Nabi Former Chief Executive Officer | 819.0K | — | 1.20M | 847.1K | 806.2K | 9.0K | 3.68M | 55.61% | ↗ |
| 75 | 2017 | Fuad El-Hibri Executive Chairman of the Board of Directors | 1.02M | — | 900.0K | 635.3K | — | 8.3K | 2.57M | 59.80% | ↗ |
| 76 | 2017 | Fuad El-Hibri Executive Chairman of the Board of Directors | 1.02M | — | 900.0K | 635.3K | — | 8.3K | 2.57M | 59.80% | ↗ |
| 77 | 2017 | Robert G. Kramer President and Chief Executive Officer | 510.1K | — | 500.0K | 331.1K | 362.3K | 9.0K | 1.71M | 48.53% | ↗ |
| 78 | 2017 | Robert G. Kramer, Sr. Executive Vice President, Administration, Chief Financial Officer and Treasurer | 510.1K | — | 500.0K | 331.1K | 362.3K | 9.0K | 1.71M | 48.53% | ↗ |
| 79 | 2017 | Robert G. Kramer, Sr. President and Chief Executive Officer | 510.1K | — | 500.0K | 331.1K | 362.3K | 9.0K | 1.71M | 48.53% | ↗ |
| 80 | 2017 | Atul Saran Executive Vice President, | 283.2K | — | 462.5K | 240.0K | 180.4K | 54.6K | 1.22M | 57.55% | ↗ |
| 81 | 2017 | Atul Saran Executive Vice President, Corporate Development, | 283.2K | — | 462.5K | 240.0K | 180.4K | 54.6K | 1.22M | 57.55% | ↗ |
| 82 | 2017 | Atul Saran Executive Vice President, Corporate Development, General Counsel and Corporate Secretary | 283.2K | — | 462.5K | 240.0K | 180.4K | 54.6K | 1.22M | 57.55% | ↗ |
| 83 | 2017 | Adam Havey Executive Vice President, Business Operations | 448.8K | — | 262.5K | 173.8K | 264.2K | 9.0K | 1.16M | 37.67% | ↗ |
| 84 | 2017 | Adam Havey Executive Vice President, Business Operations | 448.8K | — | 262.5K | 173.8K | 264.2K | 9.0K | 1.16M | 37.67% | ↗ |
| 85 | 2016 | Daniel J. Abdun-Nabi President and Chief Executive Officer | 776.6K | — | 1.20M | 743.2K | 456.6K | 8.7K | 3.19M | 61.01% | ↗ |
| 86 | 2016 | Daniel J. Abdun-Nabi President and Chief Executive Officer | 776.6K | — | 1.20M | 743.2K | 456.6K | 8.7K | 3.19M | 61.01% | ↗ |
| 87 | 2016 | Daniel J. Abdun-Nabi Former Chief Executive Officer | 776.6K | — | 1.20M | 743.2K | 456.6K | 8.7K | 3.19M | 61.01% | ↗ |
| 88 | 2016 | Fuad El-Hibri Executive Chairman of the Board of Directors | 963.6K | — | 900.0K | 557.4K | — | 8.0K | 2.43M | 60.00% | ↗ |
| 89 | 2016 | Fuad El-Hibri Executive Chairman of the Board of Directors | 963.6K | — | 900.0K | 557.4K | — | 8.0K | 2.43M | 60.00% | ↗ |
| 90 | 2016 | Robert G. Kramer, Sr. Executive Vice President, Administration, Chief Financial Officer and Treasurer | 501.7K | — | 500.0K | 259.6K | 205.2K | 8.7K | 1.48M | 51.49% | ↗ |
| 91 | 2016 | Robert G. Kramer, Sr. Executive Vice President, Administration, Chief Financial Officer and Treasurer | 501.7K | — | 500.0K | 259.6K | 205.2K | 8.7K | 1.48M | 51.49% | ↗ |
| 92 | 2016 | Robert G. Kramer, Sr. President and Chief Executive Officer | 501.7K | — | 500.0K | 259.6K | 205.2K | 8.7K | 1.48M | 51.49% | ↗ |
| 93 | 2016 | Adam Havey Executive Vice President, Business Operations | 431.0K | — | 262.5K | 136.3K | 149.6K | 8.7K | 988.1K | 40.36% | ↗ |
| 94 | 2016 | Adam Havey Executive Vice President, Business Operations | 431.0K | — | 262.5K | 136.3K | 149.6K | 8.7K | 988.1K | 40.36% | ↗ |
| 95 | 2016 | Barry Labinger Executive Vice President, Biosciences Division | 17.2K | — | — | — | — | 574.0K | 591.2K | 0.00% | ↗ |
| 96 | 2015 | Daniel J. Abdun-Nabi President and Chief Executive Officer | 790.1K | — | 1.37M | 910.2K | 566.2K | 8.0K | 3.64M | 62.55% | ↗ |
| 97 | 2015 | Daniel J. Abdun-Nabi President and Chief Executive Officer | 790.1K | — | 1.37M | 910.2K | 566.2K | 8.0K | 3.64M | 62.55% | ↗ |
| 98 | 2015 | Fuad El-Hibri Executive Chairman of the Board of Directors | 970.0K | — | 1.05M | 698.6K | — | 8.0K | 2.73M | 64.14% | ↗ |
| 99 | 2015 | Fuad El-Hibri Executive Chairman of the Board of Directors | 970.0K | — | 1.05M | 698.6K | — | 8.0K | 2.73M | 64.14% | ↗ |
| 100 | 2015 | Robert G. Kramer, Sr. Executive Vice President, Administration, Chief Financial Officer and Treasurer | 525.9K | — | 478.9K | 274.0K | 225.3K | 8.0K | 1.51M | 49.80% | ↗ |
| 101 | 2015 | Robert G. Kramer Executive Vice President, Corporate Services Division, Chief Financial Officer and Treasurer | 525.9K | 225.3K | 478.9K | 274.0K | — | 8.0K | 1.51M | 49.80% | ↗ |
| 102 | 2015 | Robert G. Kramer, Sr. Executive Vice President, Administration, Chief Financial Officer and Treasurer | 525.9K | — | 478.9K | 274.0K | 225.3K | 8.0K | 1.51M | 49.80% | ↗ |
| 103 | 2015 | Barry Labinger Executive Vice President, Biosciences Division | 463.2K | — | 312.1K | 178.6K | 212.4K | — | 1.17M | 42.07% | ↗ |
| 104 | 2015 | Adam Havey Executive Vice President, Business Operations | 443.7K | — | 270.1K | 154.5K | 197.1K | 8.0K | 1.07M | 39.56% | ↗ |
| 105 | 2015 | Adam Havey Executive Vice President, Biodefense Division | 443.7K | 197.1K | 270.1K | 154.5K | — | 8.0K | 1.07M | 39.56% | ↗ |
| 106 | 2015 | Adam Havey Executive Vice President, Business Operations | 443.7K | — | 270.1K | 154.5K | 197.1K | 8.0K | 1.07M | 39.56% | ↗ |
| 107 | 2014 | Daniel J. Abdun-Nabi President and Chief Executive Officer | 690.6K | — | 1.73M | 1.23M | 489.6K | 7.8K | 4.15M | 71.36% | ↗ |
| 108 | 2014 | Fuad El-Hibri Executive Chairman of the Board of Directors | 881.5K | — | 1.58M | 1.12M | — | 7.8K | 3.59M | 75.24% | ↗ |
| 109 | 2014 | Robert G. Kramer, Sr. Executive Vice President, Administration, Chief Financial Officer and Treasurer | 454.3K | — | 731.2K | 519.5K | 205.2K | 7.8K | 1.92M | 65.21% | ↗ |
| 110 | 2014 | Robert G. Kramer Executive Vice President, Corporate Services Division, Chief Financial Officer and Treasurer | 454.3K | 205.2K | 731.2K | 519.5K | — | 7.8K | 1.92M | 65.21% | ↗ |
| 111 | 2014 | Barry Labinger Executive Vice President, Biosciences Division | 429.7K | — | 394.9K | 280.6K | 193.5K | — | 1.30M | 52.02% | ↗ |
| 112 | 2014 | Adam Havey Executive Vice President, Biodefense Division | 385.4K | 173.3K | 394.9K | 280.6K | — | 7.8K | 1.24M | 54.39% | ↗ |
| 113 | 2014 | Adam Havey Executive Vice President, Business Operations | 385.4K | — | 394.9K | 280.6K | 173.3K | 7.8K | 1.24M | 54.39% | ↗ |
| 114 | 2013 | Daniel J. Abdun-Nabi President and Chief Executive Officer | 589.7K | 459.2K | 599.0K | 505.3K | — | 7.7K | 2.16M | 51.11% | ↗ |
| 115 | 2013 | Fuad El-Hibri Executive Chairman of the Board of Directors | 726.3K | — | 306.6K | 258.6K | — | 3.9K | 1.30M | 43.63% | ↗ |
| 116 | 2013 | Steven N. Chatfield, Ph.D. Executive Vice President, Strategic Investments Division (formerly Executive Vice President, Biosciences Division) | 361.9K | 185.6K | 175.1K | 147.7K | — | 45.7K | 916.1K | 35.25% | ↗ |
| 117 | 2013 | Barry Labinger Executive Vice President, | 138.9K | 78.5K | 317.1K | 269.4K | — | 50.0K | 853.9K | 68.68% | ↗ |
| 118 | 2013 | Barry Labinger Executive Vice President, Biosciences Division | 138.9K | 78.5K | 317.1K | 269.4K | — | 50.0K | 853.9K | 68.68% | ↗ |
| 119 | 2013 | Adam Havey Executive Vice President, Biodefense Division | 332.6K | 142.2K | 175.1K | 147.7K | — | 7.7K | 805.4K | 40.09% | ↗ |
| 120 | 2013 | Robert G. Kramer Executive Vice President, Corporate Services Division, Chief Financial Officer and Treasurer | 428.6K | 265.6K | 57.8K | 48.7K | — | — | 800.7K | 13.31% | ↗ |
| 121 | 2013 | Barry Labinger Executive Vice President, Biosciences Division | 138.9K | — | 317.1K | 269.4K | — | 50.0K | 775.4K | 75.63% | ↗ |
| 122 | 2012 | Daniel J. Abdun-Nabi President and Chief Executive Officer | 538.7K | 321.6K | 446.9K | 360.6K | — | 7.5K | 1.68M | 48.20% | ↗ |
| 123 | 2012 | Fuad El-Hibri Executive Chairman of the Board of Directors | 726.2K | 159.5K | 253.9K | 204.9K | — | 63.9K | 1.41M | 32.58% | ↗ |
| 124 | 2012 | Fuad El-Hibri Executive Chairman | 726.2K | 159.5K | 253.9K | 204.9K | — | 63.9K | 1.41M | 32.58% | ↗ |
| 125 | 2012 | Robert G. Kramer Executive Vice President, Corporate Services Division, Chief Financial Officer and Treasurer | 396.3K | 52.8K | 463.7K | 133.4K | — | — | 1.05M | 57.08% | ↗ |
| 126 | 2012 | Robert G. Kramer Executive Vice President, Corporate Services Division, Chief Financial Officer and Treasurer | 396.3K | 52.8K | 463.7K | 133.4K | — | — | 1.05M | 57.08% | ↗ |
| 127 | 2012 | Steven N. Chatfield, Ph.D. Executive Vice President, Strategic Investments Division (formerly Executive Vice President, Biosciences Division) | 344.2K | 139.4K | 174.1K | 139.9K | — | 44.7K | 842.3K | 37.27% | ↗ |
| 128 | 2012 | Adam Havey Executive Vice President, Biodefense Division | 322.1K | 130.8K | 116.0K | 93.6K | — | 7.5K | 670.1K | 31.29% | ↗ |
| 129 | 2012 | R. Don Elsey Former Senior Vice President, Finance and Administration, Chief Financial Officer | 393.8K | — | 121.9K | 98.3K | — | 7.3K | 621.3K | 35.45% | ↗ |
| 130 | 2011 | Fuad El-Hibri Executive Chairman of the Board of Directors | 692.6K | 655.2K | 969.0K | 897.1K | — | 7.4K | 3.22M | 57.93% | ↗ |
| 131 | 2011 | Fuad El-Hibri Executive Chairman | 692.6K | 655.2K | 969.0K | 897.1K | — | 7.4K | 3.22M | 57.93% | ↗ |
| 132 | 2011 | Fuad El-Hibri Chief Executive Officer and Chairman of the Board of Directors | 692.6K | 655.2K | 969.0K | 897.1K | — | 7.4K | 3.22M | 57.93% | ↗ |
| 133 | 2011 | Daniel J. Abdun-Nabi President and Chief Executive Officer | 479.8K | 288.8K | 507.2K | 469.5K | — | 7.4K | 1.75M | 55.73% | ↗ |
| 134 | 2011 | Daniel J. Abdun-Nabi President and Chief Operating Officer | 479.8K | 288.8K | 507.2K | 469.5K | — | 7.4K | 1.75M | 55.73% | ↗ |
| 135 | 2011 | Kyle W. Keese Executive Vice President, Biosciences Division | 225.1K | — | 255.9K | 236.9K | — | 448.7K | 1.17M | 42.24% | ↗ |
| 136 | 2011 | Adam Havey Executive Vice President, Biodefense Division | 309.0K | 107.5K | 246.1K | 227.8K | — | 7.4K | 897.7K | 52.79% | ↗ |
| 137 | 2011 | Adam Havey Executive Vice President, Biodefense Division | 309.0K | 107.5K | 246.1K | 227.8K | — | 7.4K | 897.7K | 52.79% | ↗ |
| 138 | 2011 | R. Don Elsey Former Senior Vice President, Finance and Administration, Chief Financial Officer | 380.6K | 165.8K | 177.5K | 164.3K | — | 7.4K | 895.5K | 38.17% | ↗ |
| 139 | 2011 | R. Don Elsey Senior Vice President, Finance and Administration, Chief Financial Officer and Treasurer | 380.6K | 165.8K | 177.5K | 164.3K | — | 7.4K | 895.5K | 38.17% | ↗ |
| 140 | 2011 | Steve Chatfield | 275.1K | 122.6K | 146.1K | 135.3K | — | 27.5K | 706.5K | 39.83% | ↗ |
| 141 | 2011 | Steven N. Chatfield, Ph.D. Executive Vice President, Strategic Investments Division (formerly Executive Vice President, Biosciences Division) | 275.1K | 122.6K | 146.1K | 135.3K | — | 27.5K | 706.5K | 39.83% | ↗ |
| 142 | 2010 | Fuad El-Hibri Chief Executive Officer and Chairman of the Board of Directors | 634.9K | 722.6K | 672.9K | 585.0K | — | 3.6K | 2.62M | 48.03% | ↗ |
| 143 | 2010 | Fuad El-Hibri Executive Chairman | 634.9K | 722.6K | 672.9K | — | — | 3.6K | 2.62M | 25.69% | ↗ |
| 144 | 2010 | Daniel J. Abdun-Nabi President and Chief Operating Officer | 452.9K | 366.7K | 352.3K | 306.3K | — | 7.4K | 1.49M | 44.33% | ↗ |
| 145 | 2010 | Daniel J. Abdun-Nabi President and Chief Executive Officer | 452.9K | 366.7K | 352.3K | 306.3K | — | 7.4K | 1.49M | 44.33% | ↗ |
| 146 | 2010 | R. Don Elsey Senior Vice President, Finance and Administration, Chief Financial Officer | 362.3K | 177.1K | 148.3K | 128.9K | — | 7.4K | 823.9K | 33.64% | ↗ |
| 147 | 2010 | R. Don Elsey Senior Vice President, Finance and Administration, Chief Financial Officer and Treasurer | 362.3K | 177.1K | 148.3K | 128.9K | — | 7.4K | 823.9K | 33.64% | ↗ |
| 148 | 2010 | R. Don Elsey Former Senior Vice President, Finance and Administration, Chief Financial Officer | 362.3K | 177.1K | 148.3K | 128.9K | — | 7.4K | 823.9K | 33.64% | ↗ |
| 149 | 2010 | Kyle W. Keese Senior Vice President, Manufacturing Operations | 335.4K | 185.9K | 139.0K | 120.8K | — | 7.4K | 788.4K | 32.95% | ↗ |
| 150 | 2010 | Kyle W. Keese Executive Vice President, Biosciences Division | 335.4K | 185.9K | 139.0K | 120.8K | — | 7.4K | 788.4K | 32.95% | ↗ |
| 151 | 2010 | Stephen Lockhart Senior Vice President, Product Development | 268.0K | 90.8K | 111.1K | 96.5K | — | 42.2K | 608.5K | 34.11% | ↗ |
| 152 | 2009 | Fuad El-Hibri Chief Executive Officer and Chairman of the Board of Directors | 585.6K | 485.9K | — | 885.5K | — | 7.4K | 1.96M | 45.08% | ↗ |
| 153 | 2009 | Daniel J. Abdun-Nabi President and Chief Operating Officer | 411.5K | 231.2K | — | 562.1K | — | 7.4K | 1.21M | 46.38% | ↗ |
| 154 | 2009 | R. Don Elsey Senior Vice President Finance and Administration, Chief | 314.7K | 142.1K | — | — | — | — | 787.4K | 0.00% | ↗ |
| 155 | 2009 | R. Don Elsey Senior Vice President, Finance and Administration, Chief Financial Officer and Treasurer | 314.7K | 142.1K | — | 323.3K | — | 7.4K | 787.4K | 41.06% | ↗ |
| 156 | 2009 | R. Don Elsey Senior Vice President, Finance and Administration, Chief Financial Officer | 314.7K | 142.1K | — | 323.3K | — | 7.4K | 787.4K | 41.06% | ↗ |
| 157 | 2009 | Kyle W. Keese Senior Vice President Manufacturing Operations | 296.7K | 143.3K | — | — | — | — | 647.6K | 0.00% | ↗ |
| 158 | 2009 | Kyle W. Keese Executive Vice President, Biosciences Division | 296.7K | 143.3K | — | 200.2K | — | 7.4K | 647.6K | 30.92% | ↗ |
| 159 | 2009 | Kyle W. Keese Senior Vice President, Manufacturing Operations | 296.7K | 143.3K | — | 200.2K | — | 7.4K | 647.6K | 30.92% | ↗ |
| 160 | 2009 | Denise Esposito | 296.2K | 109.6K | — | — | — | — | 637.9K | 0.00% | ↗ |
| 161 | 2009 | Stephen Lockhart Senior Vice President, Product Development | 265.8K | 105.9K | — | 179.7K | — | 42.2K | 593.7K | 30.27% | ↗ |
| 162 | 2008 | Fuad El-Hibri Chief Executive Officer and Chairman of the Board of Directors | 537.8K | 323.3K | — | 309.2K | — | 3.1K | 1.17M | 26.35% | ↗ |
| 163 | 2008 | Fuad El-Hibri Chief Executive Officer and Chairman of the Board of Directors | 537.8K | 323.3K | — | — | — | — | 1.00M | 0.00% | ↗ |
| 164 | 2008 | Daniel J. Abdun-Nabi President and Chief Operating Officer | 390.7K | 211.4K | — | 231.9K | — | 6.7K | 840.7K | 27.59% | ↗ |
| 165 | 2008 | R. Don Elsey Senior Vice President Finance and Administration, Chief | 296.0K | 118.6K | — | — | — | — | 553.4K | 0.00% | ↗ |
| 166 | 2008 | R. Don Elsey Senior Vice President, Finance and Administration, Chief Financial Officer | 296.0K | 118.6K | — | 133.0K | — | 5.9K | 553.4K | 24.03% | ↗ |
| 167 | 2008 | Stephen Lockhart Senior Vice President, Product Development | 295.6K | 75.7K | — | 134.2K | — | 33.9K | 539.5K | 24.88% | ↗ |
| 168 | 2008 | R. Don Elsey Senior Vice President, Finance and Administration, Chief | 296.0K | 118.6K | — | — | — | — | 535.8K | 0.00% | ↗ |
| 169 | 2008 | Kyle W. Keese Senior Vice President, Manufacturing Operations | 280.3K | 96.5K | — | 123.7K | — | 6.5K | 506.9K | 24.40% | ↗ |
| 170 | 2008 | Kyle W. Keese Senior Vice President Manufacturing Operations | 280.3K | 96.5K | — | — | — | — | 506.9K | 0.00% | ↗ |
| 171 | 2008 | Stephen Lockhart Senior Vice President, Product Development | 295.6K | 75.7K | — | — | — | — | 452.5K | 0.00% | ↗ |
| 172 | 2008 | Kyle W. Keese Senior Vice President, | 280.3K | 96.5K | — | — | — | — | 448.6K | 0.00% | ↗ |
| 173 | 2007 | Fuad El-Hibri Chief Executive Officer and Chairman of the Board of Directors | 512.5K | 307.9K | — | — | — | — | 1.03M | 0.00% | ↗ |
| 174 | 2007 | Fuad El-Hibri Chief Executive Officer and Chairman of the Board of | 512.5K | 307.9K | — | — | — | — | 824.7K | 0.00% | ↗ |
| 175 | 2007 | Daniel J. Abdun-Nabi President and Chief Operating Officer | 351.5K | 179.6K | — | — | — | — | 816.4K | 0.00% | ↗ |
| 176 | 2007 | Robert G. Kramer, Sr. President, Emergent BioDefense Operations Lansing Inc | 383.8K | 150.8K | — | 99.6K | — | 30.2K | 664.5K | 15.00% | ↗ |
| 177 | 2007 | Steven N. Chatfield, Ph.D. Executive Vice President, Strategic Investments Division (formerly Executive Vice President, Biosciences Division) | 207.7K | 72.5K | — | 199.5K | — | 27.4K | 507.1K | 39.34% | ↗ |
| 178 | 2007 | R. Don Elsey Senior Vice President, Finance and Administration, Chief Financial Officer and Treasurer | 272.9K | 91.3K | — | 132.2K | — | 7.1K | 503.5K | 26.25% | ↗ |
| 179 | 2007 | R. Don Elsey Senior Vice President, Finance and Administration, Chief | 272.9K | 91.3K | — | — | — | — | 503.5K | 0.00% | ↗ |
| 180 | 2007 | R. Don Elsey Senior Vice President Finance and Administration, Chief | 272.9K | 91.3K | — | — | — | — | 413.7K | 0.00% | ↗ |
| 181 | 2007 | Kyle W. Keese Senior Vice President, | 259.4K | 67.1K | — | — | — | — | 379.9K | 0.00% | ↗ |
| 182 | 2007 | Kyle W. Keese Senior Vice President Manufacturing Operations | 259.4K | 67.1K | — | 46.2K | — | 7.2K | 379.9K | 12.17% | ↗ |
| 183 | 2007 | Kyle W. Keese Senior Vice President Manufacturing Operations | 259.4K | 67.1K | — | — | — | — | 376.0K | 0.00% | ↗ |
| 184 | 2006 | Fuad El-Hibri Chief Executive Officer and Chairman of the Board of Directors | 509.1K | 249.1K | — | — | — | — | 868.0K | 0.00% | ↗ |
| 185 | 2006 | Fuad El-Hibri Chief Executive Officer and Chairman of the Board of Directors | 509.1K | 249.1K | — | — | — | — | 868.0K | 0.00% | ↗ |
| 186 | 2006 | Robert G. Kramer, Sr. President, Emergent BioDefense Operations Lansing Inc | 369.4K | 116.0K | — | 48.3K | — | 32.6K | 566.3K | 8.53% | ↗ |
| 187 | 2006 | Robert G. Kramer, Sr. President, Emergent BioDefense Operations Lansing Inc | 369.4K | 116.0K | — | — | — | — | 566.3K | 0.00% | ↗ |
| 188 | 2006 | Edward J. Arcuri, Ph.D. | 321.9K | 83.8K | — | — | — | — | 449.1K | 0.00% | ↗ |
| 189 | 2006 | Daniel J. Abdun-Nabi President and Chief Operating Officer | 289.8K | 101.2K | — | — | — | — | 440.2K | 0.00% | ↗ |
| 190 | 2006 | Daniel J. Abdun-Nabi President and Chief Operating Officer | 289.8K | 101.2K | — | — | — | — | 440.2K | 0.00% | ↗ |
| 191 | 2006 | R. Don Elsey Senior Vice President, Finance and Administration, Chief Financial Officer and Treasurer | 214.9K | 21.6K | — | 30.9K | — | 7.0K | 274.4K | 11.24% | ↗ |
| 192 | 2006 | R. Don Elsey Senior Vice President, Finance and Administration, Chief | 214.9K | 21.6K | — | — | — | — | 274.4K | 0.00% | ↗ |
| 193 | 2006 | R. Don Elsey Senior Vice President, Finance and Administration, Chief Financial Officer and Treasurer | 214.9K | 21.6K | — | — | — | — | 274.4K | 0.00% | ↗ |
CEO compensation breakdown
Proxy statements
Proxy statements (DEF 14A)
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Joseph C. Papa Jr. | Chief Executive Officer, President & Director | 2M | male |
| William Hartzel | Senior Vice President of Manufacturing & Bioservices | 1M | male |
| Richard S. Lindahl | Executive VP & CFO | 1M | male |
| Coleen Glessner | Executive Vice President of Quality, Ethics & Compliance | 1M | female |
| Simon C. Lowry | Chief Medical Officer & Head of Research and Development | 845.2K | male |
| Paul Williams | Senior Vice President of Products Business | 765.1K | male |
| Michelle Pepin | Senior Vice President & Chief Human Resource Officer | — | female |
| Stephanie Duatschek | Chief Global Strategy & Franchise Development Officer | — | female |
| Jessica Perl | Senior Vice President, Corporate Secretary & General Counsel | — | female |
ESG Rating
ESG Score History DRUG MANUFACTURERS - SPECIALTY & GENERIC
Benchmark vs Sector
Political Trading Activity (25M)
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
| Transaction Date | Disclosed | Representative | District | Owner | Type | Amount | Link |
|---|---|---|---|---|---|---|---|
| 2024-12-11 | 2025-01-10 | Steve Cohen | TN09 | — | Sale (Full) | $1,001 - $15,000 | ↗ |
| 2021-11-05 | 2021-12-13 | Josh Gottheimer | NJ05 | Joint | Sale (Full) | $1,001 - $15,000 | ↗ |
| 2021-10-18 | 2021-11-15 | Josh Gottheimer | NJ05 | Joint | Purchase | $1,001 - $15,000 | ↗ |
| 2021-09-15 | 2021-10-13 | Josh Gottheimer | NJ05 | Joint | Sale (Partial) | $1,001 - $15,000 | ↗ |
| 2021-02-23 | 2021-03-10 | Josh Gottheimer | NJ05 | Joint | Sale (Partial) | $1,001 - $15,000 | ↗ |
| 2020-11-24 | 2020-12-15 | Gilbert Cisneros | CA31 | — | Purchase | $1,001 - $15,000 | ↗ |
| 2020-07-30 | 2020-08-19 | Gilbert Cisneros | CA31 | — | Purchase | $1,001 - $15,000 | ↗ |
| 2020-06-30 | 2020-07-17 | Gilbert Cisneros | CA31 | — | Purchase | $1,001 - $15,000 | ↗ |
| 2020-06-26 | 2020-07-09 | Josh Gottheimer | NJ05 | Joint | Purchase | $1,001 - $15,000 | ↗ |
| 2020-06-19 | 2020-07-17 | Gilbert Cisneros | CA31 | — | Purchase | $1,001 - $15,000 | ↗ |
| 2020-06-15 | 2020-07-09 | Josh Gottheimer | NJ05 | Joint | Purchase | $1,001 - $15,000 | ↗ |
| 2020-03-26 | 2020-04-22 | Steve Cohen | TN09 | — | Sale (Full) | $1,001 - $15,000 | ↗ |
| 2019-08-29 | 2019-09-12 | Steve Cohen | TN09 | — | Sale (Full) | $15,001 - $50,000 | ↗ |
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for EBS
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
